Abstract
Transient receptor potential ankyrin 1 (TRPA1) has attracted substantial attention for its role as a thermal receptor and regulator of temperature and pain sensing. Notably, Traditional Chinese Medicine (TCM) has demonstrated pharmacological effects through regulation of TRPA1. In this review, we summarize the regulatory effects of TCM drugs and their active ingredients on TRPA1. A total of 31 TCM drugs were identified and categorized into three groups based on their function. Despite the progress in understanding the regulatory effects of TCM drugs and their constituents on TRPA1, further studies are needed to elucidate the molecular mechanisms involved. This review provides a molecular basis for the pharmacological effects of TCM drugs on TRPA1 regulation and offers evidence to support future research in this area.
1 Introduction
Traditional Chinese Medicine (TCM) is a widely used system of medicine in China, with a long history of effectiveness in addressing numerous complex diseases and major epidemics. TCM formulas are typically composed of multiple herbs, each containing various active ingredients targeting specific protein sites, thus making them highly valuable for research and potential sources for new drug development (). Clinical practice in TCM reflects a unique theory based on the Yin-Yang doctrine and describes disease conditions through the two basic patterns of cold and heat. TCM classifies herbs based on four qi (hot, warm, cold, and cool), with hot and warm herbs alleviating cold symptoms such as hypersensitivity to cold and wind, and cold and cool herbs alleviating heat symptoms such as skin redness, swelling and skin burning sensation. Transient receptor potential (TRP) ion channels are recognized as sensors of coldness and warmth (), of which transient receptor potential ankyrin 1 (TRPA1) has been identified as a cold-activated channel (; ) that plays an important role in regulating inflammation and pain (; ) (Figure 1).
FIGURE 1
At present, reviews that focus on the regulation of TRPA1 by TCM are lacking. This review summarizes the studies on TCM drugs that influence the functioning and proliferation of TRPA1, thereby offering a comprehensive overview and fostering a deeper understanding of the mechanisms underlying the pharmacological effects of TCM drugs. This essay will also serve as a reference and outline potential avenues for future research on novel drug development and modern application of TCM.
2 TRPA1
2.1 Structure
The TRPA1 gene, also known as ANKTM1, FEPS, FEPS1, p120, is a protein-coding gene. In humans, the TRPA1 gene is located on chromosome 8, band q21.11, and consists of 68,761 base pairs and 29 exons according to the updated data on NCBI. Notably, the TRPA1 gene is not limited to humans (hTRPA1) but is also found in numerous other species, including the house mouse (mTRPA1), fruit flies, dogs, and chickens.
Cryo-electron microscopic analysis has revealed that functional TRPA1 channels assemble as homotetramers through domain-swap interactions (). Each subunit consists of six transmembrane α-helices (S1-S6) flanking a re-entrant pore loop between S5 and S6, which collectively form a central cavity containing two distinct constrictions. These structural bottlenecks serve as putative gates that regulate calcium ion permeation. Notably, dual-pore helices positioned at the channel entrance exhibit selective anion exclusion through electrostatic-repulsion mechanisms ().
The intracellular domains constitute approximately 80% of TRPA1’s molecular mass (). The extensive NH2 terminus contains 14–18 ankyrin repeat domains (ARDs) that orchestrate membrane insertion, structural stability, and protein–protein interactions (; ). A unique β-hairpin-loop connector, which consists of tandem α-helices and a pre-S1 helix that structurally bridges the transmembrane core with the ARD cluster, precedes S1 (). This N-terminal region also harbors critical cysteine and lysine residues essential for agonist-binding specificity (). The other terminal of the protein is the COOH-terminal portion, which demonstrates evolutionary conservation with other TRP channels, featuring a characteristic TRP-box motif immediately following S6. This α-helical structure engages in allosteric regulation through spatial proximity to both the pre-S1 helix and distal structural elements (). Furthermore, TRPA1 possesses a putative EF-hand motif, a structural hallmark of calcium-binding proteins that may mediate its calcium sensitivity () (Figure 2).
FIGURE 2
2.2 Functions and association with disease
As a nonselective cation channel, TRPA1 demonstrates permeability to monovalent (Na+, K+) and divalent (Ca2+) ions. It also shows notably higher calcium flux than other TRP family members (), a functional characteristic consistent with its distinctive structural features. This polymodal channel integrates diverse stimuli, including cold temperature (), osmotic pressure (), and diverse electrophilic irritants ranging from environmental toxicants to endogenous algogenic lipids (). TRPA1 is widely distributed, appearing in the skin, airway, gastrointestinal tract, urinary system, vasculature, heart, and other locations (; ; ; ; ). However, its functional predominance is observed in nociceptive neurons. Specifically, TRPA1 shows preferential localization in peptidergic C-fibers (≈25% of total expression) and thinly myelinated Aδ-fibers within the peripheral nervous system (PNS), where it regulates the release of neuropeptides implicated in neurogenic inflammation, such as substance P and calcitonin gene-related peptide (CGRP) (). While central nervous system (CNS) expression of TRPA1 has been documented (; ), the central regulatory mechanisms are less clear than the well-characterized PNS functions.
The TRPA1 protein is widely expressed and can be regulated by various modulators. Therefore, it plays an important role in numerous physiological and pathological processes and is associated with a wide range of diseases, especially neurological disease, sensory-related disorders, and inflammation disease. The channel’s pathophysiological significance extends across multiple organ systems (Figure 3), serving as a crucial regulator in neuropathic pain (), migraine (), itch (), Alzheimer’s disease (), and some cardiovascular, gastrointestinal, respiratory, and urogenital diseases (). Recent studies have also reported that TRPA1 is involved in rheumatoid arthritis (), pancreatitis (), diabetes, and obesity (; ). Consequently, research and development of TRPA1 modulators holds great importance, given the large number of diseases related to TRPA1 and the anticipation that this number will continue to grow.
FIGURE 3
3 Studies on the drugs and their components in regulating pain by modulating TRPA1
Pain is a common symptom involved in various diseases and has been categorized under different classification schemes. Pain normally begins with noxious stimuli in the peripheral nerves, and is transmitted through the dorsal horn to the CNS (). Numerous studies have shown that TRPA1 is located in the CNS, thus making it an important factor in the pathological process of pain (). Moreover, TCM drugs have been shown to regulate pain through modulation of the production and function of TRPA1.
3.1 Aconiti Radix
Aconiti Radix (AR), which is derived from the dried root of Aconitum carmichaelii Debeaux (commonly referred to as Aconite, family: Ranunculaceae), is a traditional Chinese medicinal herb predominantly cultivated in southwest China’s mountainous regions (elevation, 1800–2000 m) (). The principal bioactive diterpenoid alkaloid of AR, aconitine, mediates its therapeutic effects through multimodal pharmacological activities, including anticancer, antiviral, anti-inflammatory, and analgesic properties (). Using calcium imaging, demonstrated direct TRPA1 channel blockade by aconitine (Maximal inhibition at 7 μM) and its capacity to downregulate TRPA1 expression in dorsal root ganglion (DRG) neurons of cancer-induced bone pain (CIBP) mice models. Notably, both aconitine and AR extract significantly ameliorated CIBP-associated cold/mechanical allodynia, indicating TRPA1-dependent analgesic mechanisms.
This pharmacological profile extends to classical AR-containing formulations. Wu-Tou Decoction, a canonical prescription for rheumatoid/osteoarthritis management (; ), was shown to mitigate multimodal hypersensitivity (mechanical, thermal, cold) in complete Freund’s adjuvant (CFA)-induced arthritis models (). Mechanistically, the decoction suppressed TRPA1 channel activity while reducing its protein expression, highlighting conserved TRPA1 modulation across different AR-based therapeutic preparations.
3.2 Camphor
Camphor, a bicyclic monoterpenoid predominantly isolated from Cinnamomum spp. (family: Lauraceae), demonstrates broad-spectrum bioactivities encompassing insecticidal, antimicrobial, and antitussive effects, alongside its established role as a transdermal permeation enhancer (). Historically rooted in TCM, this phytochemical has been empirically employed in managing stroke, dermatopathies, and gastrointestinal disorders. Modern pharmacological investigations by have revealed camphor’s potent suppression of TRPA1-mediated nociception: it was shown to attenuate allyl isothiocyanate (AITC)-evoked pain behaviors and ameliorate mechanical hypersensitivity in multiple TRPA1-dependent neuropathic pain models. These behavioral findings, corroborated by , strongly implicate TRPA1 channel blockade as a primary mechanism underlying the analgesic effects of camphor.
Intriguingly, structural optimization of camphor derivatives revealed enhanced TRPA1 antagonism. Through comparative calcium imaging and voltage-clamp analyses, identified borneol and fenchyl alcohol analogs as superior human TRPA1 (hTRPA1) inhibitors, demonstrating 3- to 5-fold lower half-maximal inhibitory concentration (IC50) values and near-complete channel occlusion at equimolar concentrations versus camphor (IC50 = 1.26 ± 0.32 mM). This structure-activity relationship indicates the critical pharmacophore requirements for optimal TRPA1 interaction, which likely involve hydroxyl positioning and hydrocarbon skeleton rigidity. The authors consequently proposed prioritizing the development of these analogs as next-generation TRPA1-targeted therapeutics.
3.3 Atractylodis Rhizoma
Atractylodis Rhizoma (AtR), derived from the dried rhizomes of Atractylodes lancea (Thunb.) DC. and Atractylodes chinensis (DC.) Koidz (family: Asteraceae), has been a cornerstone of East Asian traditional medicine for managing gastrointestinal dysmotility, visceral hypersensitivity, night blindness and rheumatic disorders (). Pharmacological studies have identified multimodal therapeutic properties in AtR extracts, including anticancer, anti-obesity, and anti-inflammatory activities (). Mechanistic investigations by revealed that atractylodin (AtD), a principal sesquiterpenoid constituent of AtR, is a long-acting TRPA1 agonist. Using heterologous-expression systems, they demonstrated sustained Ca2+ influx in hTRPA1-HEK293 cells upon AtD application (EC50 = 0.913 μM), an effect that was entirely abolished in TRPA1-null DRG neurons. Notably, intraplantar AtD administration induced prolonged and moderate nociceptive behaviors in comparison with injection of AITC, establishing AtD as a TRPA1 agonist that possesses a long-lasting activation effect in mice and rats. In addition to AtD, other formulas containing AtR, such as Tokishakuyakusan (Danggui Shaoyao Decoction in Kampo medicine), have also been investigated. studied Tokishakuyakusan and found that the formula could restore thermoregulatory homeostasis and normalize blood flow after cold water immersion, probably through regulation of TRPA1. Then, they tested TRPA1 activation by some ingredients of AtR and identified atractylodin carboxylic acid as a potent agonist (EC50 = 4.4 μM).
3.4 Curcumae Longae Rhizoma
Curcumae Longae Rhizoma (CLR), also known as Tumeric, is the dried rhizome of Curcuma longa L. (family: Zingiberaceae), and has been traditionally employed to manage diverse pathologies spanning gastrointestinal, cardiovascular (e.g., heart pain), respiratory (e.g., runny nose, sinusitis, asthma), and hepatic disorders (). The lipophilic polyphenolic constituent curcumin, which accounts for 2%–5% of CLR’s dry mass (), exhibits multi-channel-modulatory properties. Using high-throughput screening of thermosensitive TRP channels and taste receptors, identified curcumin-mediated inhibition of transient receptor potential vanilloid 1/2/3 (TRPV1/2/3) and TRPA1 (TRPA1 IC50 = 4.37 μM), while demethoxycurcumin (DMC) was shown to suppress TRPV3/TRPA1/TRPM8 activity in HEK293 overexpression models (TRPA1 IC50 = 7.35 μM).
Pharmacological exploration has also extended to synthetic derivatives. In streptozotocin-induced diabetic neuropathy rats models, demonstrated that J147 (a curcumin analog) elevated mechanical pain thresholds, upregulated adenosine monophosphate (AMP)-activated protein kinase (AMPK) expression, and concurrently downregulated TRPA1 levels in AITC-stimulated RSC96 Schwann cells with a better effect at 100 μM. The observed inverse correlation of AMPK and TRPA1 levels indicates that the therapeutic effects of J147 may involve AMPK-dependent suppression of TRPA1 signaling.
3.5 Angelicae Sinensis Radix
Angelicae Sinensis Radix (ASR), the dried root of Angelica sinensis (Oliv.) Diels (family: Umbelliferae), traditionally termed Danggui, is cultivated primarily in China’s Hubei and Jiangsu provinces. This botanical agent has been historically prescribed for rheumatism, gastrointestinal dysfunction, and influenza, with modern studies validating its anticancer, anti-obesity, anti-fibrotic, and anti-inflammatory properties (; ). Emerging evidence has further identified the ability of ASR to modulate central neurotransmission, cardiovascular homeostasis, and immune regulation (; ).
The therapeutic potential extends to ASR-containing formulations. Danggui Sini Decoction (DSD), a canonical cold syndrome remedy, was evaluated by D. in chronic constriction injury (CCI) rats models. DSD administration significantly attenuated cold/mechanical allodynia and thermal hyperalgesia, suppressing TRPM8, TRPV1-4, and TRPA1 protein expression in DRGs. These preliminary findings posit TRPA1 downregulation as a potential contributor to the analgesic effects of ASR, warranting mechanistic validation through targeted interrogation.
Ligustilide (Lig), a principal bioactive phthalide from ASR, displays multimodal bioactivities (). characterized two phthalide derivatives—Lig and its aromatized analog dehydroligustilide (DH-Lig) — through whole-cell voltage-clamp analyses in TRPA1-CHO cells. Both compounds activated TRPA1 (Lig IC50 = 1,456 μM and DH-Lig IC50 = 23 μM), although DH-Lig uniquely elicited post-washout current potentiation (off-response). Preactivation with mustard oil revealed DH-Lig’s superior inhibitory efficacy. Cysteine-substituted TRPA1 mutants demonstrated Lig’s dependence on specific residues versus DH-Lig’s cysteine-independent activation, indicating divergent agonistic mechanisms. Both phthalides suppressed TRPM8 while sparing TRPV1 activity. observed that ASR could attenuate cold-induced cutaneous vasospasm syndrome, so they studied the pharmacological interaction between Z-Ligustilide (Z-Lig) and ferulic acid (Fa), another bioactive component of the ASR. They performed isobolographic analysis and observed that the inhibition of TRPA1 and TRPM8 caused by Z-Lig and Fa was synergistic. The combination could also decrease RhoA activation, MLC20 phosphorylation, and cold-induced upregulation of TRPM8. This synergy extended to cold-induced RhoA/MLC20 signaling suppression, TRPA1 (Z-Lig IC50 = 6.83 ± 1.12 μM and Fa IC50 = 9.124 ± 1.04 μM) and TRPM8 (Z-Lig IC50 = 7.389 ± 1.09 μM and Fa IC50 = 8.318 ± 1.03 μM) inhibition, and normalization of TRPM8 expression, indicating multi-target modulation of thermoregulatory pathways.
Moreover, synthesized 17 Lig/DH-Lig analogs through structure-activity relationship analyses. Notably, they found that Lig and its derivatives exhibited bidirectional regulatory effects on TRPA1 and TRPM8, indicating multiple pathways were involved in the regulations. For example, the TRPA1 EC50 of 5-chloro-6-methyl-3-methylenephtahilde is 4.7 ± 0.5 μM and the IC50 is 46.7 ± 7.2 μM. Most derivatives demonstrated enhanced TRPA1/TRPM8 modulation of the two channels with EC50 and/or IC50 values distinctly lower than those of the reference compounds. These results have provided novel scaffolds for ion channel-targeted drug discovery.
3.6 Faeces Bombycis
Faeces Bombycis (FB), the dried feces of Bombyx mori Linnaeus (commnonly known as Silk Moth, family: Bombycidae), a zoological-derived traditional remedy, has been empirically prescribed for managing cephalalgia, arthralgia, and pruritic dermatoses. systematically evaluated FB’s anti-migraine potential through behavioral phenotyping and metabolomic profiling in rats models. Bioactivity-guided fractionation identified petroleum ether extracts as the most efficacious (reducing head-scratching behaviors). Among the seven purified metabolites obtained from petroleum ether extracts, phytol demonstrated superior channel-modulatory capacity, functioning as a multimodal ion channel antagonist that showed micromolar-range inhibition of Nav1.7, TRPV1, and TRPA1 with IC50 values at 0.32 ± 0.05 μM, 5.2 ± 1.1 μM and 4.6 ± 1.3 μM respectively. This 16-fold selectivity for Nav1.7 over TRP channels provides explanations for the therapeutic effect of FB on migraine and other pain-related diseases.
3.7 Notopterygii Radix et Rhizoma
Notopterygii Radix et Rhizoma (NRR), the dried rhizome and root of Notopterygium incisum Ting ex H. T. Chang or Notopterygium franchetii H. Boissieu (family: Umbelliferae) exerts pharmacological effects like anticancer, anti-inflammatory, immune-modulation, and bone-protection effects (; ; ). Using mice models of CCI- and cisplatin-induced neuropathic pain, studied the effects of water extract of NRR (WN) on cold pain and found that oral administration of WN could reduce cold and mechanical allodynia in these two pain models. They also found that WN could reduce cold pain, AITC-induced pain, and the expression of TRPA1. Then, they performed calcium imaging and found that WN inhibited the AITC-induced calcium response in HEK293 cells transfected with TRPA1 and DRG neurons. They suggested that through the regulation of TRPA1, WN reduced neuropathic pain-induced cold allodynia.
3.8 Borneol
Borneol (BO), a bicyclic monoterpene derived from Cinnamomum camphora (L.) Presl (family: Lauraceae), demonstrates extensive pharmacological activities encompassing anti-inflammatory, analgesic, and antipyretic effects, with established clinical applications in cardiovascular and cerebrovascular disease management (). Mechanistic investigations have revealed its complex interactions with TRP channels. employed calcium imaging and patch-clamp electrophysiology to quantify BO’s concentration-dependent inhibition (IC50 = 0.20 ± 0.06 μM) of TRPA1 activation triggered by menthol and allyl isothiocyanate (AITC) in HEK293 cells. further validated this TRPA1-modulating property in vivo, demonstrating that intrathecal administration of (+)-BO reversed oxaliplatin-induced mechanical hyperalgesia in mice models while preserving normal motor function and body weight during a 60-µg daily treatment regimen.
established pruritus mice models. They identified dual antipruritic mechanisms through cutaneous BO application: TRPA1/TRPM8-dependent suppression of chloroquine-induced nonhistaminergic itch via calcium flux modulation in transfected HEK293 cells and TRPA1/TRPM8-independent inhibition of compound 48/80-mediated histaminergic itch. This functional dichotomy extends to analgesia, since found that the topical application of BO preserved its antinociceptive efficacy in TRPA1-knockout mice across both capsaicin-induced acute pain and CFA-induced hyperalgesia mice models. Collectively, the mechanism underlying the pharmacological effects of BO is complex, and regulation of TRPA1 accounts for only a small portion of it.
3.9 Puerariae Lobatae Radix
Puerariae Lobatae Radix (PLR), derived from the dried root of Pueraria lobata (Willd.) Ohwi (family: Fabaceae), has been extensively documented for its multifaceted pharmacological properties. Existing pharmacological evidence has confirmed its therapeutic potential in diabetes management, oncological interventions, antiviral activity, inflammatory modulation, oxidative stress mitigation, and immune system regulation (). As the principal bioactive isoflavone constituent of PLR, puerarin’s neuropharmacological effects were systematically investigated by in a rodent neuropathic pain paradigm.
Using a neuropathic pain rat model, the research team partially ligated the sciatic nerve and administered intraperitoneal puerarin injections to evaluate its analgesic efficacy. Behavioral quantification revealed significant attenuation of mechanical allodynia and thermal hyperalgesia following puerarin intervention. Molecular analyses demonstrated dose-dependent downregulation of TRPV1 and TRPA1 mRNA overexpression after induction of neuropathy in DRG neurons. These findings mechanistically established puerarin’s capacity to ameliorate neuropathic pain through targeted suppression of TRP channel upregulation in sensory ganglia.
3.10 Croci Stigma
Croci Stigma (CS), the dried stigma of Crocus sativus L. (commonly referred to as Saffron, family: Iridaceae), demonstrates multi-target pharmacological activities, including neuroprotection, anxiolysis, depression mitigation, glycemic regulation, oxidative stress reduction, anti-inflammation, analgesia, blood pressure modulation, lipid-lowering effects, cerebral ischemia protection, and antitumor properties (). The monoterpene aldehyde safranal, a principal bioactive constituent of CS, exhibits specific TRPA1 channel-mediated pharmacological actions. In a mechanistic investigation utilizing hTRPA1-HEK293 cell models, Simone employed dynamic image analysis coupled with whole-cell patch-clamp electrophysiological assessments to demonstrate concentration-dependent TRPA1 activation by safranal (EC50 = 9 ± 0.2 μM). This activation mechanism required three critical cysteine residues, as evidenced by the abolished responses in cysteine-deficient mutant receptors.
Safranal’s target specificity was further validated in primary rodent sensory neurons. Organ bath studies revealed concentration-dependent contractions in rat urinary bladder strips, with safranal exhibiting marginally lower potency than AITC. Neuropeptide-release assays showed dose-responsive increments in CGRP-LI flow from rat spinal cord preparations. Behavioral pharmacology experiments demonstrated safranal-induced dose-dependent acute nocifensive responses upon intraplantar administration in mice. Both TRPA1 antagonist HC-030031 and genetic ablation of TRPA1 completely abolished these pharmacological effects. Notably, safranal pretreatment induced TRPA1 desensitization, significantly attenuating subsequent AITC responses. These findings establish safranal as a novel TRPA1 partial agonist capable of producing channel desensitization, indicating a dual mechanism underlying its analgesic properties through targeted TRPA1 modulation ().
In summary, a large number of TCM drugs have shown the ability to modulate TRPA1 channels, through which they can regulate pain. Among TCM drugs that are beneficial for pain-related diseases, some directly inhibit the channel, while others cause a mild activation leading to prolonged deactivation of the channel, thereby preventing activations that can produce pain. TRPA1 is strongly involved in the pathological process of neuropathic pain (). In this regard, the analgesic effects of TCM drugs may be related to the modulation of TRPA1, which may provide an explanation of the medical effects of these traditional herbals.
4 Studies on TCM drugs and their components regulating inflammation by modulating TRPA1
A growing body of literature has shown that TRPA1 is a potential target for the treatment of inflammatory disease, since it can regulate the release of the inflammatory factors such as interleukin (IL)-1 and tumor necrosis factor (TNF)-α and the functioning of immune cells such as macrophages and T cells (). Meanwhile, some TCM drugs have been shown to possess anti-inflammatory properties, which may be partly mediated through modulation of the TRPA1 channel. Some TCM drugs have been found to show both analgesic and anti-inflammatory effects, and their mechanisms are largely interwoven and interrelated.
4.1 Evodiae Fructus
Evodiae Fructus (EF), also known as Euodiae Fructus, is the almost ripe fruit of Evodia rutaecarpa (Juss.) Benth, E. rutaecarpa (Juss.) Benth. var. officinalis (Dode) Huang or E. rutaecarpa (Juss.) Benth. var. bodinieri (Dode) Huang (family: Rutaceae). The plant is primarily distributed in various provinces and cities of China, including Jiangxi and Guangxi (). EF, along with its related formulas such as Wu zhu-yu Decoction and Wen-jing Decoction, is renowned for its efficacy in treating digestive diseases and alleviating headaches (). employed a TCM-patterned irritable bowel syndrome (IBS) rats model to demonstrate the ability of the aqueous extract of EF to ameliorate weight loss/diarrhea severity, restore ATPase activity, and suppress TRPA1/TRPM8 mRNA-protein co-expression in DRG-colon axes. Rutaecarpine (Rut)—the principal quinazolinocarboline alkaloid—exerts pleiotropic effects encompassing anti-inflammatory, vasodilatory, and redox-modulatory activities (). Pharmacological explorations of Rut have extended to synthetic derivatives: developed 11 rutaecarpine-furoxan hybrids, with compound 13a exhibiting dual TRPV1/TRPA1 agonism that potentiates CGRP secretion, representing a strategic approach for the development of newer antihypertensive drugs.
4.2 Cinnamomi Cortex
Cinnamomi Cortex (CC), also known as Cinnamon, is derived from the dried bark of Cinnamomum cassia Presl (family: Lauraceae), which is predominantly cultivated in China’s Guangdong and Guangxi provinces, and serves dual roles as a culinary spice and a traditional analgesic/thermogenic agent (). Pharmacological profiling has revealed its multifunctional therapeutic potential: glycemic control through insulin modulation (), antiviral defense (), antithrombotic activity (), antitumor effects (), and cardioprotection against ischemia-reperfusion injury ().
Mechanistic studies by employed high-performance liquid chromatography (HPLC)-quadrupole time of flight (Q-TOF)/mass spectrometry (MS) metabolomics with pathway enrichment analysis to delineate CC’s thermoregulatory actions. Three principal constituents enhanced lipolytic metabolism and brown adipocyte activation via upregulation of UCP1, PGC1-α, and pHSL expression, concomitantly stimulating TRPA1 in DRG neurons.
Cinnamaldehyde (CNA) is an essential oil extracted from CC () and is responsible for the efficacy and bioactivity of CC (; ). used a vascular cognitive impairment (VCI) mice model and observed that CNA could improve the cognitive function and myelin density of the model, and that these inhibitory effects diminished significantly in TRPA1 gene-knockout mice. This suggests that CNA can ameliorate VCI through regulation of TRPA1. observed that CC and CNA could preserve the expression of TRPA1 in a overreactive bladder (OAB) mice model. They used cyclophosphamide (CYP) to induce typical OAB pathophysiological changes in the model mice, and TRPA1 expression was found to be downregulated in model mice. However, treatment with CC and CNA significantly ameliorated the CYP-induced dysfunction in micturition patterns and pathophysiological changes and suppressed local inflammation, while preserving the expression of TRPA1. However, administration of HC-030031 (a TRPA1 agonist) did not cause significant improvement in CYP-induced abnormal micturition patterns. Thus, the ameliorative effects of CNA on VCI are mediated through the regulation of TRPA1, while in the case of OAB, the preservation of TRPA1 expression by CC and CNA appears to be beneficial, although direct activation of TRPA1 was not found to be involved in the amelioration.
4.3 Alpiniae Officinarum Rhizoma
Alpiniae Officinarum Rhizoma (AOR), also known as Lesser Galangal, is derived from the dried rhizome of Alpinia officinarum Hance (family: Zingiberaceae), which is indigenously cultivated in subtropical regions of southern China and Vietnam (), and possesses broad-spectrum pharmacological properties including antioxidant, antidiabetic, and antiemetic activities (). used an IBS mice model to demonstrate AOR aqueous extract’s therapeutic capacity: ameliorating weight loss/diarrhea severity, restoring ATPase functionality, and suppressing TRPA1/TRPM8 mRNA-protein co-expression along the DRG-colon axis. These multimodal effects provide mechanistic linkage to AOR’s traditional thermogenic and analgesic properties through dual regulation of TRP channel homeostasis.
4.4 Zingiberis Rhizoma
Zingiberis Rhizoma (ZR), which is derived from the dried rhizome of Zingiber officinale Roscoe (commonly referred to as Ginger, family: Zingiberaceae), exhibits therapeutic potential across multiple disease domains. Clinically applied for gastrointestinal disorders such as nausea, vomiting, abdominal discomfort, and diarrhea, ZR has also demonstrated efficacy in arthritis, rheumatism, musculoskeletal pain, cardiovascular conditions, and metabolic dysregulation (). The traditional Chinese medicine formula Da-Jian-Zhong Decoction (DJZD), which incorporates ZR as a key component, shows notable activity against abdominal pain (; ).
elucidated the pivotal role of ZR in mediating DJZD’s anti-inflammatory effects using a mice postoperative ileus model. Their investigation revealed ZR’s dual capacity to enhance intestinal motility and reduce CD68-positive macrophage infiltration within ileal muscular layers. Pharmacological interventions with HC-030031 attenuated both ZR/DJZD-induced anti-inflammatory responses and 5-hydroxytryptamine (5-HT) secretion from RIN-14B cells exposed to gingerols/shogaols, indicating that TRPA1 channel activation in enterochromaffin (EC) cells was the mechanistic basis for macrophage suppression. Subsequent research employing analogous methodologies further demonstrated TRPA1-mediated prevention of neutrophil infiltration by these agents ().
The existing evidence has identified zingerone, shogaols and gingerols as the principal bioactive constituents of ZR (; ). documented 6-shogaol’s capacity to induce calcium influx and generate action potentials in nodose C-fibers through TRPA1 activation, with subsequent application desensitization specific to 6-shogaol but not mechanical stimuli. established that vincristine-induced vagal nociceptor activation in upper gastrointestinal tissues requires TRPA1/5-HT3 receptor co-activation, a process effectively inhibited by 6-shogaol. Complementary cellular studies by demonstrated gingerol-induced calcium mobilization and subsequent serotonin/cholecystokinin secretion in RIN14B/STC-1 cells, which was completely abrogated by TRPA1 antagonists (ruthenium red), calcium chelation (EGTA), and Trpa1 gene silencing. These findings collectively implicate the potential of ZR-derived compounds in modulating gastrointestinal function through TRPA1-dependent endocrine signaling pathways.
4.5 Schisandrae Chinensis Fructus
Schisandrae Chinensis Fructus (SCF), also known as Schisandra Berry, which is derived from the dried ripe fruit of Schisandra chinensis (Turcz.) Baill. (family: Magnoliaceae), exhibits diverse pharmacological properties encompassing antioxidant, anti-inflammatory, anti-osteoporotic, antidepressant, and antitussive effects (; ; ). In a seminal study by , a cigarette smoke-induced cough hypersensitivity model was established in guinea pigs. Both ethanol extracts (EEs) and ethanol-water extracts (EWEs) of SCF demonstrated significant efficacy in reducing 0.4M citric acid-evoked cough frequency. Notably, pretreatment with these extracts markedly attenuated cigarette smoke-induced pulmonary neutrophilic infiltration and total inflammatory cell accumulation, concurrently suppressing elevated pulmonary malondialdehyde, TNF-, and IL-8 levels. Parallel enhancements in pulmonary superoxide dismutase (SOD) and glutathione (GSH) activities were observed, highlighting the extracts’ antioxidative capacity.
Histopathological analysis revealed that 1 g/kg EE pretreatment substantially mitigated airway epithelial hyperplasia, smooth muscle thickening, and inflammatory cell infiltration. Mechanistically, this treatment downregulated TRPV1 and TRPA1 expression in pulmonary tissues. Complementary in vitro investigations using A549 cells demonstrated that four specific Schisandra lignans from the EE dose-dependently inhibited cigarette smoke extract-induced TRPV1, TRPA1, and endothelial nitric oxide synthase (NOS3) expression, while concurrently suppressing nitric oxide (NO) release. These findings collectively elucidate the multimodal therapeutic mechanisms of SCF in respiratory pathophysiology.
4.6 Zanthoxyli Pericarpium
Zanthoxyli Pericarpium (ZP), also known as Sichuan Pepper, is derived from the dried pericarp of mature fruits from Zanthoxylum schinifolium Sieb. Et Zucc. or Zanthoxylum bungeanum Maxim. (family: Rutaceae), and has been pharmacologically characterized for its anti-inflammatory, analgesic, antioxidant, antitumor, antimicrobial, and insecticidal properties (). In a study by , chronic eczema was induced in a rat model via 2-dinitrochlorobenzene (DNCB) sensitization. Comparative gas chromatography (GC)-MS analysis of volatile oil constituents between ZP and Z. schinifolium (ZS) revealed distinct compositional profiles.
Both medium-dose ZP and ZS interventions significantly improved the eczema area and severity index (EASI) values, which are a validated metric of antipruritic efficacy, while reducing scratching frequency. These treatments concurrently suppressed serum concentrations of IL-4, IgE, gastrin-releasing peptide (GRP), and histamine, in addition to downregulating protein expression of histamine H1 receptor (H1R), protease-activated receptor 2 (PAR-2), TRPV1, and gastrin-releasing peptide receptor (GRPR). Notably, while TRPA1 protein expression remained unchanged between model and blank controls, all ZP dosage groups and the ZS group exhibited significant TRPA1 upregulation. Paradoxically, TRPA1 mRNA levels were elevated in model animals but markedly reduced following ZP/ZS administration across all tested doses. This discordance between transcriptional and translational regulation of TRPA1 highlights the need for mechanistic investigations into the modulatory effects of ZP on this molecular target.
4.7 Paeoniae Radix
Paeoniae Radix Alba (white peony root) and Paeoniae Radix Rubra (red peony root), botanically derived from the dried roots of Paeonia lactiflora Pall. or Paeonia veitchii Lynch (commonly known as Chinese Peony, family: Ranunculaceae), are pharmacologically analogous herbs collectively termed Paeoniae Radix (PR) in traditional Chinese medicine. PR and its bioactive constituents exhibit multifaceted therapeutic properties, including anti-inflammatory, immunoregulatory, antitumor, antimicrobial, antioxidant, hepatoprotective, and neuroprotective activities (). Paeoniflorin (PAE), the principal active glycoside isolated from PR, demonstrates significant neuromodulatory effects (). In a neuropathic pain model, demonstrated that oral PAE administration attenuated mechanical allodynia through multiple pathyways: downregulating TRPM8, TRPV1, and TRPA1 expression in DRGs, and suppressing p38 mitogen-activated protein kinase (MAPK) phosphorylation and proinflammatory cytokine release. In vitro experiments further revealed PAE’s capacity to inhibit H2O2-induced TRPA1/TRPV1 upregulation and p38MAPK activation in Schwann cells, indicating a reactive oxygen species (ROS)-mediated pathway modulation (). investigated PAE’s gastrointestinal effects using a loperamide-induced constipation model. PAE treatment normalized intestinal motility, reduced histopathological colonic damage, and enhanced enterochromaffin cell function through Tph1-dependent 5-HT biosynthesis. Mechanistically, PAE upregulated TGR5 receptor expression and activated PLC-γ1/PIP2 signaling cascades in RIN-14B cells, with TRPA1 channel involvement confirmed by TGR5 inhibition experiments These findings collectively elucidate PAE’s dual regulatory role in neuronal sensitization and enteric neurotransmitter regulation.
4.8 Rhei Radix et Rhizoma
Rhei Radix et Rhizoma (RRR), commonly referred to as Rhubarb, is derived from the dried roots of Rheum palmatum L., Rheum tanguticum Maxim. Ex Balf., or Rheum officinale Baill. (family: Polygonaceae). Contemporary pharmacological studies have demonstrated that RRR exhibits multifaceted bioactivities, including antitumor effects, modulation of gastrointestinal microbiota, intestinal mucosal barrier protection, anti-inflammatory properties, and antifibrotic potential (). Notably, systematically investigated the hepatotoxic profile of RRR through a comprehensive approach. Using ultra-high-performance liquid chromatography (UPLC)-Q-TOF/MS technology, the researchers first characterized the chemical constituents in RRR extracts. Subsequently, three dose cohorts and a control group of rats received oral administration of these extracts, with plasma samples collected for metabolomic profiling. Through principal component analysis (PCA) and partial least squares discriminant analysis (PLS-DA), nine distinct metabolic biomarkers associated with RRR-induced hepatotoxicity were identified.
The investigation further employed computational target prediction to map hepatotoxic metabolites against known RRR components. Gene ontology (GO) enrichment and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses revealed potential molecular mechanisms, implicating key targets such as DRD1, DRD2, PDE4B, TRPV1, TRPM8, TRPA1, PTGER2, ACHE, and CHRM3. These findings suggest that RRR-induced hepatotoxicity may involve dysregulation of cyclic AMP (cAMP) signaling, cholinergic synaptic transmission, and TRP channel-related inflammatory mediators. This mechanistic elucidation provides critical insights into the dual pharmacological and toxicological characteristics of RRR.
4.9 Glycyrrhizae Radix et Rhizoma
Glycyrrhizae Radix et Rhizoma (GRR), the dried root and rhizome derived from Glycyrrhiza uralensis Fisch., Glycyrrhiza inflata Bat., or Glycyrrhiza glabra L. (commonly known as Licorice or Liquorice, family: Fabaceae), has been pharmacologically demonstrated to possess multifunctional therapeutic properties. The existing research has confirmed its broad-spectrum bioactivities encompassing antitumor, antimicrobial, antiviral, anti-inflammatory, antidiabetic, immunomodulatory, hepatoprotective, and neuroprotective effects, along with adrenal cortical hormone-mimetic properties (). Liquiritin (LIQ) is the main flavonoid compound and active ingredient of GRR.
Through whole-cell patch-clamp electrophysiology, identified LIQ’s bidirectional inhibitory effects on agonist-activated TRPV1 (IC50 = 9.8 ± 1.5 μM) and TRPA1 (IC50 = 16.2 ± 1.1 μM) currents. In lipopolysaccharide (LPS)-induced acute lung injury mice models, oral LIQ administration demonstrated multimodal protective efficacy: attenuating pulmonary histopathological damage, suppressing inflammatory responses, and inhibiting both nuclear factor (NF)-κB signaling activation and LPS-triggered upregulation of TRPV1/TRPA1 expression at translational (lung tissue proteins) and transcriptional (bronchoalveolar lavage fluid mRNA) levels. Parallel in vitro experiments using THP-1 monocytes revealed LIQ’s capacity to counteract cytokine-mediated NF-κB activation and concomitant TRPV1/TRPA1 overexpression, mirroring the effects of pharmacological antagonists. These findings establish a mechanistic link between LIQ’s anti-inflammatory/antitussive actions and its dual-channel inhibition of NF-κB-dependent TRPV1/TRPA1 upregulation in non-neuronal cells, effectively disrupting the proinflammatory positive feedback loop in airway inflammation.
4.10 Lycii Fructus
Lycii Fructus (LF), also known as Goji Berry, derived from the dried ripe fruits of Lycium barbarum L. (family: Solanaceae), is a TCM herb primarily used to tonify the liver and kidney while enhancing ocular function. Existing pharmacological investigations have demonstrated its multifunctional properties, including antioxidant, antimicrobial, immunomodulatory, and anti-inflammatory activities (). Polysaccharides, identified as the principal bioactive constituents of LF, are considered critical mediators of its therapeutic efficacy (). In a mechanistic study by , dextran sulfate sodium (DSS)-induced ulcerative colitis (UC) rat models were orally administered L. barbarum polysaccharides (LBP). This intervention significantly attenuated serum malondialdehyde levels and IL-6 concentrations, while concurrently elevating catalase activity. At the colonic level, LBP administration substantially reduced TNF-α expression and downregulated TRPV1 and TRPA1 channel protein expression. Notably, co-administration of LBP with capsaicin demonstrated synergistic effects, exhibiting enhanced suppression of serum IL-6 and colonic TNF-α levels, along with more pronounced inhibition of TRPA1 protein expression in comparison with monotherapy. These findings collectively indicate LBP-mediated modulation of oxidative stress and inflammatory pathways in UC pathophysiology.
4.11 Platycodi Radix
Platycodi Radix (PlaR), the desiccated root system of Platycodon grandiflorum (Jacq.) A. DC. (commonly referred to as Balloon Flower, family: Campanulaceae), demonstrates multi-pharmacological efficacy, including expectorant, antitussive, anti-inflammatory, antineoplastic, anti-obesity, hypoglycemic, immunoregulatory, cardiovascular protective, and hepatoprotective properties (). In a lipopolysaccharide (LPS)-induced pneumonia mice model established by , PlaR treatment exhibited the following dose-dependent therapeutic effects: (1) alleviation of LPS-induced pulmonary histopathological alterations; (2) suppression of the production of the proinflammatory cytokines TNF-α and IL-1β; and (3) downregulation of TRPA1 mRNA and protein overexpression. Notably, high-dose PlaR administration induced modest TRPA1 upregulation in healthy controls, although the upregulation was significantly less pronounced than LPS-induced activation. They also identified five primary platycodins in PlaR water extract, and Platycodin D3 showed the highest affinity for TRPA1 through molecular docking and experimental validation.
4.12 Chuanxiong Rhizoma
Chuanxiong Rhizoma (CR) is the desiccated rhizome of Ligusticum chuanxiong Hort. (family: Apiaceae). Contemporary pharmacological investigations have demonstrated that CR possesses multifunctional therapeutic properties, including antioxidant activity, anti-inflammatory effects, ischemic injury protection ability, and immunomodulatory capacity, with clinical applications in dysmenorrhea and diabetes management (; ). Ligustrazine, identified as the principal bioactive compound mediating the therapeutic efficacy of CR (), was systematically investigated by using a mice model of chronic venous disease (CVeD)-induced nociception. Their experimental design revealed that ligustrazine administration significantly attenuated mechanical allodynia and thermal/cold hyperalgesia induced by venous ligation.
Through electrophysiological patch-clamp recordings and calcium imaging analyses, the researchers elucidated ligustrazine’s capacity to desensitize TRPA1 channels in DRG neurons. The compound demonstrated additional therapeutic mechanisms by suppressing macrophage infiltration and downregulating mRNA expression levels of IL-1β and NLRP3 inflammasome components in DRG tissues. Notably, while these therapeutic effects were observed in vivo, in vitro experiments using TRPA1-transfected HEK293 cells showed no direct channel blockade. This dichotomy indicates that ligustrazine’s antinociceptive action in CVeD primarily involves indirect modulation of TRPA1 activity through inhibition of inflammatory pathways rather than direct receptor antagonism.
Notably, ligustilide, another pharmacologically significant constituent of CR(), exhibits contrasting TRPA1 activation properties as detailed in Section 3.5, highlighting the complex pharmacodynamics of CR’s multi-component system.
4.13 Sophorae Flavescentis Radix
Sophorae Flavescentis Radix (SFR), the dried root of Sophora flavescens Ait. (family: Fabaceae Lindl.), has been demonstrated through contemporary pharmacological studies to exhibit multi-target therapeutic properties, including physiological regulation, anti-aging, antitumor, anti-inflammatory, and immunomodulatory effects (; ). Using computational approaches combining data mining with bioinformatics, suggested that TRPA1 was the convergent molecular target of SFR, Fructus Cnidii (FC), and pruritus pathogenesis. GO and KEGG analyses further identified calcium ion homeostasis and the calcium signaling pathway as critical biological processes within this target network, indicating the central role of TRPA1 in mediating the antipruritic effects of SFR and FC.
Oxymatrine (OMT), a quinolizidine alkaloid isolated from SFR, demonstrates broad pharmacological activity (). employed DRG-cell membrane immobilized chromatography to identify five bioactive SFR compounds. Using four distinct pruritus models (chloroquine [CQ], Ser-Leu-Ile-Gly-Arg-Leu [SLIGRL], histamine [HIS], and AITC), they observed that OMT significantly attenuated scratching behavior in CQ- and SLIGRL-induced mice models (histamine-independent pathways), and its dose-dependent efficacy was correlated with TRPA1 mRNA downregulation. Notably, OMT also suppressed AITC-induced nociceptive responses. In a complementary study by using a squaric acid dibutyl ester (SADBE)-induced allergic contact dermatitis (ACD) murine model, all three OMT formulations (gel, microgel powder, microgel cream) effectively reduced facial wiping and scratching episodes while mitigating cutaneous inflammation. The optimized oxymatrine microgel cream (OMC) formulation exhibited superior therapeutic outcomes, including restoration of epidermal keratinization patterns, reduction of peripheral leukocytosis, and systemic downregulation of proinflammatory mediators (IL-1β, TNF-α, CXCR3, CXCL10, IL-6, IL-10, IL-17A, IL-31), along with suppression of TRPA1/TRPV1 expression in trigeminal ganglia and cytokine modulation in thymic interferon (IFN)-γ and splenic IL-17A tissues. Comparative analysis established OMC as the most effective dosage form through multimodal mechanisms involving chemokine regulation, immune mediator modulation, and TRP channel inhibition.
4.14 Tetrapanacis Medulla
Tetrapanacis Medulla (TM), the dried stem pith of Tetrapanax papyrifer (Hook.) K. Koch (commonly known as Rice-paper Plant, family: Araliaceae), serves as a traditional botanical source of hederagenin. This pentacyclic triterpenoid demonstrates diverse pharmacological properties, including antitumor, anti-inflammatory, antidepressant, anti-neurodegenerative, antihyperlipidemic, antidiabetic, anti-leishmaniasis, and antiviral activities (). used KEGG pathway analysis and identified “inflammatory mediator regulation of TRP channels” as the most significantly enriched pathway. Subsequent experiments utilizing a CCI rat model revealed that both oral TM administration and hederagenin treatment effectively alleviated the manifestations of neuropathic pain, specifically mechanical/thermal hyperalgesia, cold allodynia, and tactile hypersensitivity. Biochemical analyses demonstrated TM’s capacity to significantly reduce serum concentrations of proinflammatory cytokines (IL-1β, IL-6, TNF-α). At the molecular level, TM and hederagenin coordinately downregulated the expressions of multiple transient receptor potential channels (TRPM8, TRPA1, TRPV1, TRPV4) in DRGs and inhibited phosphorylation of p38 MAPK.
In general, TCM drugs can modulate TRPA1 as part of a complex, multimodal mechanism to suppress the release of inflammatory factors and macrophage infiltration, with TRPA1 being one of several contributing targets. Some of them downregulate TRPA1 protein and mRNA expression, while some others preserve the expression reduced by some pathological process. We have also noticed that herbal drugs such as ZP modulate the expression of mRNA and protein oppositely, and herbal drugs such as PR and CR activate and inhibit the channel under different conditions. These diverse modulations of TRPA1 indicate the need for more studies to characterize the anti-inflammatory effects of TCM drugs.
5 Studies on TCM drugs and their components with agonistic or inhibitory effects on TRPA1
Some TCM drugs and their ingredients have been found to be TRPA1 agonists/antagonists, and their activities are mostly accomplished by monitoring intracellular Ca2+ levels. However, the metabolic pathways and pathological processes underlying these TCM drugs and their ingredients remain to be elucidated.
5.1 Piperis Fructus
Piperis Fructus (PF), the fruits of Piper nigrum L. (commonly referred to as Pepper, family: Piperaceae), which has been globally utilized as a culinary spice and phytotherapeutic agent, demonstrates a multifaceted pharmacological profile that includes antimicrobial, neuroprotective, and immunoregulatory activities (; ). Yukiko Okumura et al. () systematically characterized 19 PF-derived alkaloids using heterologously expressed human TRPV1/TRPA1-HEK293 models. Notably, 18 of the 19 compounds evoked concentration-dependent intracellular Ca2+ mobilization through both channel subtypes, with complete response attenuation by specific antagonists (AMG9810 for TRPV1, HC-030031 for TRPA1). Mechanistically, piperine/isopiperine emerged as dual TRPV1/TRPA1 agonists, providing molecular rationale for the traditional medicinal applications of PF.
5.2 Allii Sativi Bulbus
Allii Sativi Bulbus (ASB), also known as Garlic, is the bulb of Allium sativum L. (family: Liliaceae). It is a globally consumed culinary-medicinal bulb that has been empirically utilized in TCM for its thermogenic, detoxicant, and anti-inflammatory properties (). These properties are attributed to its antioxidant, immunomodulatory, and metabolic regulatory activities (). quantified intracellular Ca2+ flux in TRPA1/TRPV1-CHO models using organosulfur compounds (diallyl sulfide/disulfide/trisulfide), demonstrating dual-channel agonist activity with preferential TRPA1 activation with EC50 at 254, 7.55 and 0.49 μM respectively. corroborated these findings through fluorescent imaging plate reader (FLIPR)-based calcium imaging, and their findings showed ASB extract-induced dose-dependent activation of both channels. Allicin has emerged as the predominant activator (EC50 for mTRPA1, hTRPA1 and rTRPV1 were 1.32 μM, 1.91 μM, and 51.22 μM), with methodological assessments using comparative FLIPR-nuclear magnetic resonance (NMR) quantification confirming allicin’s concentration-dependent pungency. These convergent results establish allicin as the primary mediator of ASB’s TRP channel-mediated bioactivity.
5.3 Alpiniae Katsumadai Semen
Alpiniae Katsumadai Semen (AKS), also known as Katsumada’s Galangal, which is derived from the dried near-mature seeds of Alpinia katsumadai Hayata (family: Zingiberaceae), exhibits multimodal bioactivities, including antioxidant, antineoplastic, and nociception-modulating effects (; ). Cardamonin, the principal chalcone constituent, mediates the bioactivities of AKS through pro-apoptotic, cell cycle-modulatory, and autophagy-inducing mechanisms ().
Mechanistic insights from the study by identified cardamonin’s selective TRPA1 antagonism via calcium influx assays complemented by molecular docking. This chalcone demonstrated concentration-dependent TRPA1 blockade (IC50 = 454 nM) with structural compatibility at the A-967079-binding pocket, while remaining inert toward TRPV1/V4. Cytotoxicity profiling (CellTiter-Glo/xCELLigence RTCA systems) confirmed preserved HEK293 viability and unaltered cardiomyocyte contractility, validating its therapeutic safety window.
5.4 Asari Radix et Rhizoma
Asari Radix et Rhizoma (ARR), also known as Wild Ginger, is the dried root and rhizome of Asarum heterotropoides Fr. Schmidt var. Mandshuricum (Maxim.) Kitag., Miq. var. Seoulense Nakai or Asarum sieboldii Miq (family: Aristolochiaceae). It is a botanical source of analgesic, anticonvulsant, and anti-inflammatory agents, and has been integrated into traditional formulations such as Mahuang Fuzi Xixin Decoction (MFXD). Network pharmacology analysis by identified TRPA1 as the convergent molecular target linking ARR’s bioactive components with migraine pathophysiology. ARR is also present in numerous TCM formulas, such as MFXD. performed qualitative non-targeted analysis utilizing high-resolution MS to identify the bioactive ingredients of ARR, and quantitative targeted analysis to identify the plasma concentrations following oral administration of maobushisaishinto (MFXD in Kampo medicine) in rats. Then, they performed in vitro pharmacological studies of bioactive ARR ingredients in addition to other ingredients of MFXD to reveal that methyl kakuol (EC50 = 0.27 μM), Amide A (EC50 = 0.47 μM), Asarinin (EC50 = 3.1 μM), Sesamin (EC50 = 2.3 μM) and other compounds derived from ARR were detected in rat plasma and showed agonistic activity on the TRPA1 channel. Their research indicates that methyl kakuol and other compounds may be novel TRPA1 agonists and may contribute in part to the bioactive effects of ARR and MFXD.
5.5 Perillae Fructus/Perillae Folium
Perillae Fructus/Folium (PFB), which consists of the dried ripe fruits and foliar young branches of Perilla frutescens (L.) Britt. (commonly referred to as Perilla, family: Lamiaceae), exhibits broad-spectrum bioactivities, including antioxidant, anticancer, and antimicrobial effects (). Angela characterized two principal sesquiterpenoids, perillaldehyde (EC50 = 41.0 ± 7.5 μM) and perillaketone (EC50 = 19.7 ± 1.7 μM), as potent TRPA1 agonists in heterologous-expression systems. Building on these lead compounds, subsequent structure-activity relationship studies (; ) yielded novel synthetic analogs with enhanced TRPA1 activation profiles. These findings collectively establish PFB as a valuable phytochemical repository for developing TRP channel-targeted therapeutics.
5.6 Waldheimia glabra (Decne.) Regel
Waldheimia glabra (Decne.) Regel (WR), a perennial herb belonging to the Asteraceae family and endemic to the Himalayan Mountains, has been employed in ethnomedicine for millennia to manage dermatological conditions, cephalalgia, arthralgia, and pyrexia. performed headspace solid-phase microextraction (HS-SPME) GC/MS, GC/MS, and NMR analyses to identify the two main components of WR: (+)-Ludartin (EC50 = 36.9 ± 5.7 μM) and B-ring-homo-tonghaosu (EC50 = 40.4 ± 3.8 μM) (compound 1 and 2). They then tested the efficacy of WR extracts and two compounds in the TRPA1-or TRPM8-transfected HEK293 cells. Although all tested extracts and compounds exhibited minimal inhibitory effects on rat TRPM8 channels, significant agonist activity was observed at TRPA1 receptors. Notably, both compounds demonstrated relatively low potency as TRPA1 agonists. Of particular structural interest, compound 2 represents a previously uncharacterized spirocyclic scaffold in TRPA1 agonist pharmacology, indicating its potential utility as a lead compound for developing novel TRPA1-targeting therapeutics.
5.7 Kalopanax pictus Nakai
Kalopanax pictus Nakai (KPN), a deciduous tree belonging to the Araliaceae family, is predominantly distributed in East Asia. The dried leaves and bark of this species have been historically employed for the management of diverse pathological conditions in traditional medicine across China and neighboring Asian countries. Contemporary pharmacological investigations have revealed that KPN exhibits multifaceted therapeutic potential, including anti-inflammatory, antinociceptive, antidiabetic, and anticancer properties ().
In a pivotal study by , calcium imaging analyses were performed on cultured cells expressing human TRPA1 (hTRPA1) and TRPV1 (hTRPV1) channels. Their findings demonstrated that 80% EEs derived from KPN leaves induced time- and concentration-dependent intracellular Ca2+ influx through both hTRPA1 and hTRPV1 activation. Notably, this TRPA1-mediated response was significantly attenuated by co-treatment with ruthenium red (a broad-spectrum TRP channel antagonist) and HC-030031 (a selective TRPA1 inhibitor). Subsequent pharmacological evaluation of six bioactive compounds isolated from KPN revealed that methyl syringate exhibited selective agonistic activity toward hTRPA1 (EC50 = 507.4 µM), while showing negligible effects on hTRPV1. These results established methyl syringate as a novel natural product with specific TRPA1-activating properties ().
6 Conclusions and perspectives
Our review provides a summary of the TCM drugs that act on TRPA1 to enhance the understanding of the pharmacological effects of TCM drugs and to provide evidence for further research on the molecular basis of novel drug development and modern application of TCM. In addition to the TCM drugs and ingredients mentioned above, some other compounds extracted from TCM drugs and formulas have also been shown to act on TRPA1, and the information regarding these herbs and their ingredients is comprehensively summarized in Table 1. Some other TCM formulas have also been proven to regulate TRPA1 through modern pharmacological research, and these formulas are listed in Table 2.
TABLE 1
| Name of the drug | Species tested | Pharmacologic effect | Regulatory effect on TRPA1 | Compounds and potencies | References |
|---|---|---|---|---|---|
| Aconiti Radix (AR) | Mouse | Alleviates CIBP-induced cold allodynia and mechanical allodynia | Inhibits activity and reduces protein expression | Aconitine (not determined) | |
| Evodiae Fructus (EF) | Rat | Reduces inflammatory cell infiltration | Suppresses protein and mRNA expression | Rutaecarpine (not determined) | |
| Cinnamomi Cortex (CC) | Mouse | Preserves the structure of the bladder tissue from inflammation | Preserves expression | Cinnamaldehyde (not determined) | |
| Alpiniae Officinarum Rhizoma (AOR) | Moue | Reduces the infiltration of inflammatory cells | Suppress protein and mRNA expression | not determined | |
| Piperis Fructus (PF) | Human | Agonist | Upregulates protein expression and activates the channel | Piperine (EC50 = 29.7 μM) (Emax = 77%) Isopiperine (EC50 = 32.6 μM) (Emax = 84.8%) Isochavicine (EC50 = 71.1 μM) Piperanine (EC50 = 148.3 μM) Piperolein A (EC50 = 7.8 μM) (Emax = 89.9%) Piperolein B (EC50 = 11.1 μM) (Emax = 70.4%) | |
| Zingiberis Rhizoma (ZR) | Mouse | Reduces CD68-positive macrophage infiltration | Activates the channel | 6- shogaol (not determined) Gingerol (not determined) Zingerone (not determined) | |
| Camphor | Mouse | Reduces nociceptive behavior | Inhibits activity and reduces protein expression | Camphor (IC50 = 1.26 ± 0.32 mM) | |
| Atractylodis Rhizoma (AtR) | Mouse Rat | Evokes moderate and prolonged nociceptive behavior; accelerates the recovery of model rats’ body surface temperature, rectal temperature, and blood flow after the cold water immersion | Activates the channel | Atractylodin, (EC50 = 0.913 μM) atractylodin carboxylic acid (EC50 = 4.4 μM) | Jun et al. (2018), |
| Allii Sativi Bulbus (ASB) | Mouse Human | Agonist | Activates the channel | Diallyl sulfide (EC50 = 254 μM) (Emax = 90.8%) Diallyl disulfide (EC50 = 7.55 μM) (Emax = 76.6%) Diallyl trisulfide (EC50 = 0.49 μM) (Emax = 83.6%) Allicin (mTRPA1 EC50 = 1.32 μM) (hTRPA1 EC50 = 1.91 μM) | |
| Curcumae Longae Rhizoma (CLR) | Rat | Reduces the mechanical withdrawal threshold in a rat model | Downregulates expression and inhibits activation | Curcumin (IC50 = 4.37 μM) Demethoxycurcumin (IC50 = 7.35 μM) | |
| Angelicae Sinensis Radix (ASR) | Rat | Reduces cold allodynia, mechanical allodynia, and thermal hyperalgesia | Activates and inhibits under different conditions | Ligustilide (IC50 = 1,456 μM) (EC50 = 44 μM) Dehydroligustilide (IC50 = 23 μM) Z-Ligustilide (IC50 = 6.83 ± 1.12 μM) Ferulic Acid (IC50 = 9.124 ± 1.04 μM) | ; |
| Faeces Bombycis (FB) | Rat | Reduces migraine behaviors (head scratching) | Inhibits activity and reduces protein expression | Phytol (IC50 = 0.32 ± 0.05 μM) | |
| Alpiniae Katsumadai Semen (AKS) | not determined | Antagonist | Inhibits activity and reduces protein expression | Cardamonin (IC50 = 454 nM) | |
| Chuanxiong Rhizoma (CR) | Mouse | Restricts macrophage infiltration and decreases the mRNA levels of IL-1β | Activates and inhibits under different conditions | Ligustrazine (not determined) Ligustilide (IC50 = 1,456 μM) (EC50 = 44 μM) | |
| Asari Radix et Rhizoma (ARR) | Rat | Agonist | Activates the channel | Methyl kakuo (EC50 = 0.27 μM) Amide A (EC50 = 0.47 μM) Asarinin (EC50 = 3.1 μM) Sesamin (EC50 = 2.3 μM) | |
| Notopterygii Radix et Rhizoma (NRR) | Mouse | Reduces cold and mechanical allodynia and AITC-induced pain | Downregulates expression and inhibits activation | not determined | |
| Schisandrae Chinensis Fructus (SCF) | Guinea Pig | Attenuates the CS-induced increase in infiltration of pulmonary neutrophils and total inflammatory cells, as well as pulmonary MDA, TNF-α, and IL-8 levels | Downregulates expression | not determined | |
| Zanthoxyli Pericarpium (ZP) | Rat | Decreases the concentrations of IL-4, IgE, GRP, and histamine | Upregulates protein expression and downregulates mRNA expression | not determined | |
| Perillae Fructus/Perillae Folium (PFB) | Rat | Agonist | Activates the channel | Perillaldehyde (EC50 = 41.0 ± 7.5 μM) Perillaketone (EC50 = 19.7 ± 1.7 μM) | |
| Borneol (BO) | Moue | Alleviates mechanical and thermal hyperalgesia | Inhibits activity | Borneol (IC50 = 0.20 ± 0.06 μM) | |
| Paeoniae Radix (PR) | Rat | Reduces the expression of proinflammatory cytokines such as IL-6 and TNF-α, preserves the structure of the colonic tissue, and reduces the infiltration of inflammatory cells | Activates and inhibits under different conditions | Paeoniflorin (not determined) | |
| Sophorae Flavescentis Radix (SFR) | Mouse | Rescues defects in epidermal keratinization and lymphocyte infiltration, downregulates the mRNA expression of IL-1β, TNF-α, CXCR3, CXCL10, IL-6, IL-10, IL-17A, and IL-31 | Downregulates mRNA expression | Oxymatrine (not determined) | |
| Rhei Radix et Rhizoma (RRR) | not determined | Causes minor connective tissue hyperplasia and fibroblasts, with occasional granulocyte presence and lymph cell infiltration in the liver tissue | Unclear | not determined | |
| Tetrapanacis Medulla (TM) | Rat | Reduces the levels of IL-1β, IL-6, and TNF-α in the serum of the CCI rat model | Downregulates expression | Hederagenin (not determined) | |
| Puerariae Lobatae Radix (PLR) | Rat | Ameliorates mechanical allodynia and thermal hyperalgesia | Downregulates mRNA expression | Puerarin (not determined) | |
| Glycyrrhizae Radix et Rhizoma (GRR) | Mouse | Prevents increases in the number of inflammatory cells such as neutrophils and macrophages and the levels of cytokines such as TNF-α, IL-6, and IL-1β | Downregulates mRNA and protein expression | Liquiritin (IC50 = 16.2 ± 1.1 μM) | |
| Lycii Fructus (LF) | Rat | Decreases serum malondialdehyde and IL-6 and colonic TNF-α levels | Downregulates protein expression | Lycium barbarum Polysaccharides (not determined) | |
| Waldheimia glabra (Decne.) Regel (WR) | Rat | Agonist | Activates the channel | (+)-Ludartin (EC50 = 36.9 ± 5.7 μM) B-ring-homo-tonghaosu (EC50 = 40.4 ± 3.8 μM) | |
| Kalopanax Pictus Nakai (KPN) | Human | Agonist | Activates the channel | Methyl syringate (EC50 = 507.4 µM) | |
| Platycodi Radix (PlaR) | Mouse | Suppresses or reduces the production and release of TNF-α and IL-1β | Downregulates and upregulates the expression of mRNA and protein, inhibits activity | Platycodins D3 (not determined) | |
| Croci Stigma (CS) | Mouse | Evokes a dose-dependent acute nociceptive response in mouse model | Activates the channel | Safranal (EC50 = 9 ± 0.2 μM) | (; ) |
List of TCMs and related compounds that regulate TRPA1.
TABLE 2
| Name of the formula | Species tested | Herbs included | Regulatory effects on TRPA1 | References |
|---|---|---|---|---|
| Danggui Sini Decoction | Rat | Cinnamomum cassia Presl, Paeonia lactiflora Pallas Tetrapanax papyriferus Radix Angelica sinensis, Glycyrrhiza uralensis Fisch Asarum heterotropoides Ziziphus jujuba Mill | Downregulates expression of the protein, inhibits protein activity | (; ; ) |
| Zhenxin Anshen Formula | Mouse | Os Draconis Concha Ostreae Rhizoma Drynariae Poria Herba Lophatheri | Downregulates mRNA and protein expression | |
| Houpo-Mahuang Decoction | Mouse | Magnolia officinalis Rehder et E.H. Wilson Ephedra intermedia Schrenk et C.A. Mey Gypsum fibrosum Prunus armeniaca L Zingiber officinale Roscoe Asarum heterotropoides F. Schmidt Schisandra chinensis (Turcz.) Baill., Pinellia ternata (Thunb.) Makino Triticum aestivum L | Downregulates mRNA and protein expression | |
| Yanghe Decoction | Rat | Radix Rehmanniae Praeparata Colla Cornus Cervi Cortex Cinnamomi Cassiae Semen Sinapis Herba Ephedra Sinica Ginger charcoal Radix Glycyrrhizae | Downregulates mRNA and protein expression | |
| Goshajinkigan (Jisheng Shenqi Pills) | Rat | Rehmanniae radix Achyranthis radix Corni fructus Moutan cortex Alismatics rhizome Dioscoreae rhizome Plantaginis semen Hoelen, processed Aconiti tuber, Cinnamomi cortex | Inhibits activity | (; ) |
| Banhasasim-tang (Banxia Xiexin Decoction) | Mouse | Pinellia ternata (Thunb.) Makino (tuber), Scutellaria baicalensis Georgi (root) Zingiber officinale Roscoe (fresh) (rhizome) Panax ginseng C.A.Mey. (root) Glycyrrhiza uralensis Fisch. Ex DC. (rhizome) Ziziphus jujuba Mill. (fruit) Coptis chinensis Franch. (rhizome) Zingiber officinale Roscoe (dried) (rhizome) | Inhibits activity | |
| Qingpeng Ointment | Mouse | Oxytropis falcata Bunge Rheum lhasaense Aconitum pendulum Busch, Terminalia chebula Retz (stoned), Terminalia billerica (Gaertn.) Roxb Phyllanthus emblica Linn Styrax tonkinensis (Pierre) Craib ex Hartw Tinospora sinensis (Lour.) Merr Synthetic musk | Downregulates mRNA expression | |
| Daikenchuto(Da-Jian-Zhong-Tang) | Mouse | Zingiberis Rhizoma (Ginger) Panax ginseng (Ginseng; Ginseng radix) Zanthoxyli fructus (Japanese pepper), malt sugar | Upregulates protein expression and activates the channel | |
| Sanse Powder | Rat | Forsythia suspensa Glycyrrhiza uralensis Salvia miltiorrhiza Gentiana macrophylla Chaenomeles sinensis Strychnos nux-vomica Ligusticum striatum Hort Curcuma longa Paeonia lactiflora Notopterygium root Saposhnikovia divaricata | Downregulates mRNA and protein expression | (; ) |
| Maobushisaishinto (Mahuang Fuzi Xixin Decoction) | Rat | Ephedrae Herba Aconiti Radix Processa Asiasari Radix | Activates the channel | |
| Shugan Decoction | Rat | White atractylodes rhizome, white peony root, dried old orange peel, ledebouriella root Radix bupleuri | Inhibits activity | |
| Tokishakuyakusan (Danggui Shaoyao San) | Rat | Peony Root Atractylodes lancea Rhizome Alisma Tuber Poria Sclerotium Cnidium Rhizome Japanese Angelica Root | Activates the channel | |
| Wu-Tou Decoction | Mouse | Aconiti Radix Cocta Herba Ephedrae Paeoniae Radix Alba Astragali Radix Glycyrrhiza Radix Preparata | Downregulates protein expression and inhibits activity | |
| San’ao Decoction | Mice | Herba Ephedrae Semen Armeniacae amarum Radix Glycyrrhizae | Downregulates mRNA and protein expression and inhibits activity | (; ) |
| Chi-Huang Solution | Mouse | Scutellaria baicalensis Georgi Sophora flavescens Aiton Paeonia lactiflora Pall Rehmannia glutinosa (Gaertn.) DC Lycium barbarum L Plantago asiatica L Dictamnus albus L Cnidium monnieri (L.) Cusson Bassia scoparia (L.) A.J.Scott | Downregulates mRNA expression |
List of TCM formulas that regulate TRPA1.
TCM is of great value and possesses the potential to serve as a resource for the development of new drugs. However, further investigations of TCM drugs acting on TRPA1 still need to be conducted since the existing studies are relatively superficial and limited in number. For example, some TCM components have dual-directional regulatory effects on TRPA1 function and expression, indicating that these compounds show activating or inhibitory effects depending on their concentration. Apart from this, some TCM ingredients display mild and long-lasting desensitization effects on TRPA1, whereas other TCM drugs exhibit antagonistic effects on the channel. Moreover, the species investigated in current research are predominantly limited to rodents and humans. Since the compounds discussed are mainly non-electrophilic, their primary mode of interaction with TRPA1 is non-covalent binding, occurring within a pocket formed by the TRP-like domain and the pre-S1, S4, and S5 helices of one subunit (). This pocket is species-specific, and therefore, the modulation of TRPA1 can differ across species, even for the same compound (; ). Thus, studies involving more species are required to further explore the mechanisms and regulatory principles underlying TRPA1 modulation by TCM. All these special bioactivities differentiate them from the agonists, antagonists, and desensitizers that are already known, and may be the key point to clarify the efficacy of TCM. Therefore, the mechanisms underlying these effects require elucidation.
In conclusion, we hope that this review will provide reference for future TCM studies on TRPA1, facilitate the development of novel drugs, and offer new directions for modernization of TCM.
Statements
Author contributions
YF: Conceptualization, Writing – original draft, Writing – review and editing. CL: Writing – original draft. ZW: Project administration, Supervision, Writing – review and editing. LL: Project administration, Supervision, Writing – review and editing. YC: Project administration, Supervision, Writing – review and editing. FC: Project administration, Supervision, Writing – review and editing. JL: Project administration, Supervision, Writing – review and editing. ZT: Project administration, Supervision, Writing – review and editing. QT: Writing – review and editing. YX: Conceptualization, Writing – review and editing.
Funding
The author(s) declare that financial support was received for the research and/or publication of this article. This work was financially supported in part by the National Natural Science Foundation of China (reference: 82474275 and 82204901).
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Generative AI statement
The author(s) declare that no Generative AI was used in the creation of this manuscript.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1
AbubakarI. B.MalamiI.YahayaY.SuleS. M. (2018). A review on the ethnomedicinal uses, phytochemistry and pharmacology of Alpinia officinarum Hance. J. Ethnopharmacol.224, 45–62. 10.1016/j.jep.2018.05.027
2
AdhyaP.SharmaS. S. (2019). Redox TRPs in diabetes and diabetic complications: mechanisms and pharmacological modulation. Pharmacol. Res.146, 104271. 10.1016/j.phrs.2019.104271
3
AhmadN.BasriA.TahaH. (2017). A review on the pharmacological activities and phytochemicals of Alpinia officinarum (Galangal) extracts derived from bioassay-guided fractionation and isolation. Pharmacogn. Rev.11 (21), 43–56. 10.4103/phrev.phrev_55_16
4
AhmedT.WangC.-K. (2021). Black garlic and its bioactive compounds on human health diseases: a review. Molecules26 (16), 5028. 10.3390/molecules26165028
5
AzietakuJ. T.MaH.YuX.-a.LiJ.OppongM. B.CaoJ.et al (2017). A review of the ethnopharmacology, phytochemistry and pharmacology of Notopterygium incisum. J. Ethnopharmacol.202, 241–255. 10.1016/j.jep.2017.03.022
6
BaeW.-Y.ChoiJ.-S.KimJ.-E.JeongJ.-W. (2015). Cinnamic aldehyde suppresses hypoxia-induced angiogenesis via inhibition of hypoxia-inducible factor-1α expression during tumor progression. Biochem. Pharmacol.98 (1), 41–50. 10.1016/j.bcp.2015.08.095
7
BainD. (2015). Pharmacological and biochemical action of Angelica sinensis (Dong Quai): natural product with therapeutic potential. Int. J. Recent Res. Life Sci.2, 8–23. Available online at: https://www.paperpublications.org/upload/book/Pharmacological%20and%20Biochemical%20Action%20of%20Angelica%20Sinensis-401.pdf
8
BalestriniA.JosephV.DouradoM.ReeseR. M.ShieldsS. D.RougéL.et al (2021). A TRPA1 inhibitor suppresses neurogenic inflammation and airway contraction for asthma treatment. J. Exp. Med.218 (4), e20201637. 10.1084/jem.20201637
9
BassoliA.BorgonovoG.CaimiS.ScaglioniL.MoriniG.MorielloA. S.et al (2009). Taste-guided identification of high potency TRPA1 agonists from Perilla frutescens. Bioorg. and Med. Chem.17 (4), 1636–1639. 10.1016/j.bmc.2008.12.057
10
BassoliA.BorgonovoG.MoriniG.De PetrocellisL.Schiano MorielloA.Di MarzoV. (2013). Analogues of perillaketone as highly potent agonists of TRPA1 channel. Food Chem.141 (3), 2044–2051. 10.1016/j.foodchem.2013.05.063
11
BenemeiS.De CesarisF.FusiC.RossiE.LupiC.GeppettiP. (2013). TRPA1 and other TRP channels in migraine. J. Headache Pain14 (1), 71. 10.1186/1129-2377-14-71
12
CaoX.LiuY.WangM.SunL.RenX. (2018). Study on the source and characteristics of Evodia rutaecarpa based on chemical pattern recognition. Nat. Prod. Res.33 (14), 2113–2115. 10.1080/14786419.2018.1484464
13
CattaneoA. M.BobkovY. V.CoreyE. A.BorgonovoG.BassoliA. (2017). Perilla derived compounds mediate human TRPA1 channel activity. Med. and Aromatic Plants06 (01). 10.4172/2167-0412.1000283
14
ChenG.LuF.XuL.DongH.YiP.WangF.et al (2013a). The anti-diabetic effects and pharmacokinetic profiles of berberine in mice treated with Jiao-Tai-Wan and its compatibility. Phytomedicine20 (10), 780–786. 10.1016/j.phymed.2013.03.004
15
ChenJ.KangD.XuJ.LakeM.HoganJ. O.SunC.et al (2013b). Species differences and molecular determinant of TRPA1 cold sensitivity. Nat. Commun.4, 2501. 10.1038/ncomms3501
16
ChenJ. H.WeiC. M.LinQ. Y.WangZ.ZhangF. M.ShiM. N.et al (2024a). Notopterygium incisum extract promotes apoptosis by preventing the degradation of BIM in colorectal cancer. Curr. Med. Sci.44, 833–840. 10.1007/s11596-024-2883-1
17
ChenL.FanB.WangF.SongY.WangX.MengY.et al (2024b). Research progress in pharmacological effects and mechanisms of Angelica sinensis against cardiovascular and cerebrovascular diseases. Molecules29 (9), 2100. 10.3390/molecules29092100
18
ChenL.-L.LeeM.-H.ChangC.-L.LiouK.-T.LiuS.-H.ChernC.-M.et al (2021). Suppression of inflammatory and fibrotic signals by cinnamon (Cinnamomum cassia) and cinnamaldehyde in cyclophosphamide-induced overactive bladder in mice. Evidence-Based Complementary Altern. Med.2021, 5205759–13. 10.1155/2021/5205759
19
ChenM.DingY.TongZ. (2020). Efficacy and safety of Sophora flavescens (kushen) based traditional Chinese medicine in the treatment of ulcerative colitis: clinical evidence and potential mechanisms. Front. Pharmacol.11, 603476. 10.3389/fphar.2020.603476
20
ChenW.VermaakI.ViljoenA. (2013c). Camphor—a fumigant during the black death and a coveted fragrant wood in ancient Egypt and babylon—a review. Molecules18 (5), 5434–5454. 10.3390/molecules18055434
21
ChenY.-S.LianY. Z.ChenW.-C.ChangC.-C.TinkovA. A.SkalnyA. V.et al (2022). Lycium barbarum polysaccharides and capsaicin inhibit oxidative stress, inflammatory responses, and pain signaling in rats with dextran sulfate sodium-induced colitis. Int. J. Mol. Sci.23 (5), 2423. 10.3390/ijms23052423
22
ChenZ.ZhangC.GaoF.FuQ.FuC.HeY.et al (2018). A systematic review on the rhizome of Ligusticum chuanxiong Hort. (Chuanxiong). Food Chem. Toxicol.119, 309–325. 10.1016/j.fct.2018.02.050
23
ChoiJ. E.Di NardoA. (2018). Skin neurogenic inflammation. Seminars Immunopathol.40 (3), 249–259. 10.1007/s00281-018-0675-z
24
ChoiN. R.KwonM. J.ChoiW.-G.KimS. C.ParkJ.-W.NamJ. H.et al (2023). The traditional herbal medicines mixture, Banhasasim-tang, relieves the symptoms of irritable bowel syndrome via modulation of TRPA1, NaV1.5 and NaV1.7 channels. J. Ethnopharmacol.312, 116499. 10.1016/j.jep.2023.116499
25
CvetkovT. L.HuynhK. W.CohenM. R.Moiseenkova-BellV. Y. (2011). Molecular architecture and subunit organization of TRPA1 ion channel revealed by electron microscopy. J. Biol. Chem.286 (44), 38168–38176. 10.1074/jbc.M111.288993
26
de LimaR. M. T.dos ReisA. C.de MenezesA. A. P. M.SantosJ. V. d.O.FilhoJ. W. G. d.O.FerreiraJ. R. d.O.et al (2018). Protective and therapeutic potential of ginger (Zingiber officinale) extract and [6]‐gingerol in cancer: a comprehensive review. Phytotherapy Res.32 (10), 1885–1907. 10.1002/ptr.6134
27
DiZ.ZhenniC.ZifengZ.BeiJ.YongC.YixuanL.et al (2024). Danggui Sini Decoction normalizes the intestinal microbiota and serum metabolite levels to treat sciatica. Phytomedicine132, 155740. 10.1016/j.phymed.2024.155740
28
EarleyS. (2012). TRPA1 channels in the vasculature. Br. J. Pharmacol.167 (1), 13–22. 10.1111/j.1476-5381.2012.02018.x
29
EndoM.HoriM.MiharaT.OzakiH.OikawaT.OdaguchiH.et al (2017). Zingiberis Siccatum Rhizoma, the active component of the Kampo formula Daikenchuto, induces anti‐inflammatory actions through α7 nicotinic acetylcholine receptor activation. Neurogastroenterol. and Motil.29 (12). 10.1111/nmo.13139
30
EndoM.HoriM.OzakiH.OikawaT.OdaguchiH.HanawaT. (2018). Possible anti-inflammatory role of Zingiberis processum rhizoma, one component of the Kampo formula daikenchuto, against neutrophil infiltration through muscarinic acetylcholine receptor activation. J. Pharmacol. Sci.137 (4), 379–386. 10.1016/j.jphs.2018.08.001
31
FuJ.LiJ.SunY.LiuS.SongF.LiuZ. (2023). In-depth investigation of the mechanisms of Schisandra chinensis polysaccharide mitigating Alzheimer's disease rat via gut microbiota and feces metabolomics. Int. J. Biol. Macromol.232, 123488. 10.1016/j.ijbiomac.2023.123488
32
FujikaneA.SakamotoA.FujikaneR.NishiA.IshinoY.HiromatsuK.et al (2022). Ephedrae Herba and Cinnamomi Cortex interactions with G glycoprotein inhibit respiratory syncytial virus infectivity. Commun. Biol.5 (1), 94. 10.1038/s42003-022-03046-z
33
GalindoT.ReynaJ.WeyerA. (2018). Evidence for transient receptor potential (TRP) channel contribution to arthritis pain and pathogenesis. Pharmaceuticals11 (4), 105. 10.3390/ph11040105
34
GaoY.FanH.NieA.YangK.XingH.GaoZ.et al (2022). Aconitine: a review of its pharmacokinetics, pharmacology, toxicology and detoxification. J. Ethnopharmacol.293, 115270. 10.1016/j.jep.2022.115270
35
GaudetR. (2008). A primer on ankyrin repeat function in TRP channels and beyond. Mol. Biosyst.4 (5), 372–379. 10.1039/b801481g
36
GawalskaA.KołaczkowskiM.BuckiA. (2022). Structural modeling of TRPA1 ion channel-determination of the binding site for antagonists. Molecules27 (10), 3077. 10.3390/molecules27103077
37
GiorgiA.BassoliA.BorgonovoG.PanseriS.ManzoA.PentimalliD.et al (2017). Extracts and compounds active on TRP ion channels from Waldheimia glabra, a ritual medicinal plant from Himalaya. Phytomedicine32, 80–87. 10.1016/j.phymed.2017.04.012
38
GongH.LiY.FengL.XiaoY. J.HuangL. Z.MaoD.et al (2022). Yanghe decoction attenuated pain hypersensitivity induced by Michigan cancer foundation-7 injection in rats with bone metastases from breast cancer by inhibiting transient receptor potential ankyrin 1. J. Traditional Chin. Med.42 (6), 948–955. 10.19852/j.cnki.jtcm.20220707.001
39
GongX.XiongH.LiuS.LiuY.YinL.TuC.et al (2019). Qingpeng ointment ameliorates inflammatory responses and dysregulation of itch-related molecules for its antipruritic effects in experimental allergic contact dermatitis. Front. Pharmacol.10, 354. 10.3389/fphar.2019.00354
40
HeG.WangX.LiuW.LiY.ShaoY.LiuW.et al (2023a). Chemical constituents, pharmacological effects, toxicology, processing and compatibility of Fuzi (lateral root of Aconitum carmichaelii Debx): a review. J. Ethnopharmacol.307, 116160. 10.1016/j.jep.2023.116160
41
HeJ.ZhangY.YangC.LiK.YuanX.ZhangZ.et al (2023b). Effects of Alpinia Officinarum and Euodia Rutaecarpa on the expression of TRPA1 and TRPM8 in rats with irritable bowel syndrome. J. Holist. Integr. Pharm.4 (1), 1–13. 10.1016/s2707-3688(23)00091-2
42
HiraishiK.KuraharaL.-H.SumiyoshiM.HuY.-P.KogaK.OnitsukaM.et al (2018). Daikenchuto (Da-Jian-Zhong-Tang) ameliorates intestinal fibrosis by activating myofibroblast transient receptor potential ankyrin 1 channel. World J. Gastroenterology24 (35), 4036–4053. 10.3748/wjg.v24.i35.4036
43
HouT.NetalaV. R.ZhangH.XingY.LiH.ZhangZ. (2022). Perilla frutescens: a rich source of pharmacological active compounds. Molecules27 (11), 3578. 10.3390/molecules27113578
44
HuangX.ShenQ. K.GuoH. Y.LiX.QuanZ. S. (2023). Pharmacological overview of hederagenin and its derivatives. RSC Med. Chem.14 (10), 1858–1884. 10.1039/d3md00296a
45
HuangY.PatilM. J.YuM.LiptakP.UndemB. J.DongX.et al (2019). Effects of ginger constituent 6‐shogaol on gastroesophageal vagal afferent C‐fibers. Neurogastroenterol. and Motil.31 (6), e13585. 10.1111/nmo.13585
46
HuoJ.-G.AnZ.-T.GuZ.-C.WeiG.-L.LuW.-G.ZhuJ.-P.et al (2020). Danggui Sini decoction protects against oxaliplatin-induced peripheral neuropathy in rats. J. Integr. Neurosci.19 (4), 663–671. 10.31083/j.jin.2020.04.1154
47
JiangX. W.LiuW. W.WuY. T.WuQ.LuH. Y.XuZ. H.et al (2020). Notopterygium incisum extract (NRE) rescues cognitive deficits in APP/PS1 Alzhneimer's disease mice by attenuating amyloid-beta, tau, and neuroinflammation pathology. J. Ethnopharmacol.249, 112433. 10.1016/j.jep.2019.112433
48
JiangY.-B.ZhongM.HuangT.DaiZ.-H.TaoX.-B.YangR.-P. (2021). Network pharmacology-based elucidation of the molecular mechanism underlying the anti-migraine effect of Asari Radix et Rhizoma. Trop. J. Pharm. Res.18 (10), 2067–2074. 10.4314/tjpr.v18i10.10
49
JinX.ChengJ.ZhangQ.JiH.ZhuC.YangY.et al (2023). Aconitine – a promising candidate for treating cold and mechanical allodynia in cancer induced bone pain. Biomed. and Pharmacother.161, 114284. 10.1016/j.biopha.2023.114284
50
JunX.FuP.LeiY.ChengP. (2018). Pharmacological effects of medicinal components of Atractylodes lancea (Thunb.) DC. Chin. Med.13 (1), 59. 10.1186/s13020-018-0216-7
51
KádkovÁA.SynytsyaV.KrusekJ.ZímovÁL.VlachovÁV. (2017). Molecular basis of TRPA1 regulation in nociceptive neurons. A review. Physiological Res.66, 425–439. 10.33549/physiolres.933553
52
KakaeM.NakajimaH.ToboriS.KawashitaA.MiyanoharaJ.MorishimaM.et al (2023). The astrocytic TRPA1 channel mediates an intrinsic protective response to vascular cognitive impairment via LIF production. Sci. Adv.9 (29), eadh0102. 10.1126/sciadv.adh0102
53
KandaH.YangY.DuanS.KogureY.WangS.IwaokaE.et al (2021). Atractylodin produces antinociceptive effect through a long-lasting TRPA1 channel activation. Int. J. Mol. Sci.22 (7), 3614. 10.3390/ijms22073614
54
KashioM.TominagaM. (2022). TRP channels in thermosensation. Curr. Opin. Neurobiol.75, 102591. 10.1016/j.conb.2022.102591
55
KatoY.TateaiY.OhkuboM.SaitoY.AmagaiS.-y.KimuraY.-s.et al (2014). Gosha-jinki-gan reduced oxaliplatin-induced hypersensitivity to cold sensation and its effect would be related to suppression of the expression of TRPM8 and TRPA1 in rats. Anti-Cancer Drugs25 (1), 39–43. 10.1097/cad.0000000000000022
56
KheradpezhouhE.ChoyJ. M. C.DariaV. R.ArabzadehE. (2017). TRPA1 expression and its functional activation in rodent cortex. Open Biol.7 (4), 160314. 10.1098/rsob.160314
57
KimY.-S.HongC. S.LeeS. W.NamJ. H.KimB. J. (2016). Effects of ginger and its pungent constituents on transient receptor potential channels. Int. J. Mol. Med.38 (6), 1905–1914. 10.3892/ijmm.2016.2791
58
KocaadamB.ŞanlierN. (2015). Curcumin, an active component of turmeric (Curcuma longa), and its effects on health. Crit. Rev. Food Sci. Nutr.57 (13), 2889–2895. 10.1080/10408398.2015.1077195
59
KoizumiK.IwasakiY.NarukawaM.IitsukaY.FukaoT.SekiT.et al (2009). Diallyl sulfides in garlic activate both TRPA1 and TRPV1. Biochem. Biophysical Res. Commun.382 (3), 545–548. 10.1016/j.bbrc.2009.03.066
60
KoonrungsesomboonN.Na-BangchangK.KarbwangJ. (2014). Therapeutic potential and pharmacological activities of Atractylodes lancea (Thunb.) DC. Asian Pac. J. Trop. Med.7 (6), 421–428. 10.1016/s1995-7645(14)60069-9
61
KumariN.KumarM.Radha, LorenzoJ. M.SharmaD.PuriS.et al (2022). Onion and garlic polysaccharides: a review on extraction, characterization, bioactivity, and modifications. Int. J. Biol. Macromol.219, 1047–1061. 10.1016/j.ijbiomac.2022.07.163
62
KuruvillaM.KalangaraJ.Eun-Hyung LeeF. (2019). Neuropathic pain and itch mechanisms underlying allergic conjunctivitis. J. Investigational Allergology Clin. Immunol.29 (5), 349–356. 10.18176/jiaci.0320
63
LeeG. I.NeumeisterM. W. (2020). Pain: pathways and physiology. Clin. Plast. Surg.47 (2), 173–180. 10.1016/j.cps.2019.11.001
64
LiC.ZhangJ.LiuH.YuanH.CaiJ.FogaçaM. V.et al (2023a). The synergistic mechanism of action of Dajianzhong decoction in conjunction with ketamine in the treatment of depression. Biomed. Pharmacother.165, 115137. 10.1016/j.biopha.2023.115137
65
LiH.ParkJ. H.LeeJ.-C.YooK.-Y.HwangI. K.LeeC. H.et al (2012). Neuroprotective effects ofAlpinia katsumadaiagainst experimental ischemic damage via control of oxidative stress. Pharm. Biol.51 (2), 197–205. 10.3109/13880209.2012.716853
66
LiJ.-j.ZhangX.ShenX.-c.LongQ.-d.XuC.-y.TanC.-j.et al (2020). Phytochemistry and biological properties of isoprenoid flavonoids from Sophora flavescens Ait. Fitoterapia143, 104556. 10.1016/j.fitote.2020.104556
67
LiM.ZhangL.LiuZ.ZhangL.XingR.YinS.et al (2021a). Sanse powder essential oil nanoemulsion negatively regulates TRPA1 by AMPK/mTOR signaling in synovitis: knee osteoarthritis rat model and fibroblast-like synoviocyte isolates. Mediat. Inflamm.2021, 4736670–15. 10.1155/2021/4736670
68
LiS.WangY.LiC.YangN.YuH.ZhouW.et al (2021b). Study on hepatotoxicity of rhubarb based on metabolomics and network pharmacology. Drug Des. Dev. Ther.15, 1883–1902. 10.2147/dddt.S301417
69
LiZ.GanY.KangT.ZhaoY.HuangT.ChenY.et al (2023b). Camphor attenuates hyperalgesia in neuropathic pain models in mice. J. Pain Res.16, 785–795. 10.2147/jpr.S398607
70
LiZ.HeX.LiuF.WangJ.FengJ. (2018). A review of polysaccharides from Schisandra chinensis and Schisandra sphenanthera: properties, functions and applications. Carbohydr. Polym.184, 178–190. 10.1016/j.carbpol.2017.12.058
71
Li PumaS.LandiniL.MacedoS. J.SeravalliV.MaroneI. M.CoppiE.et al (2019). TRPA1 mediates the antinociceptive properties of the constituent of Crocus sativus L., safranal. J. Cell. Mol. Med.23 (3), 1976–1986. 10.1111/jcmm.14099
72
LiuS.YangL.ZhengS.HouA.ManW.ZhangJ.et al (2021). A review: the botany, ethnopharmacology, phytochemistry, pharmacology of Cinnamomi cortex. RSC Adv.11 (44), 27461–27497. 10.1039/d1ra04965h
73
LiuY.ZhangH.LuW.JiangT. (2023). Integrating metabolomics, 16S rRNA sequencing, network pharmacology, and metorigin to explore the mechanism of Cinnamomi Cortex in treating chronic atrophic gastritis rats. Phytomedicine121, 155084. 10.1016/j.phymed.2023.155084
74
LiuZ.WangP.LuS.GuoR.GaoW.TongH.et al (2020). Liquiritin, a novel inhibitor of TRPV1 and TRPA1, protects against LPS-induced acute lung injury. Cell Calcium88, 102198. 10.1016/j.ceca.2020.102198
75
LvJ.CaoL.ZhangR.BaiF.WeiP. (2018). A curcumin derivative J147 ameliorates diabetic peripheral neuropathy in streptozotocin (STZ)-induced DPN rat models through negative regulation AMPK on TRPA1. Acta Cir. Bras.33 (6), 533–541. 10.1590/s0102-865020180060000008
76
MaJ.ChenL.FanJ.CaoW.ZengG.WangY.et al (2019). Dual-targeting Rutaecarpine-NO donor hybrids as novel anti-hypertensive agents by promoting release of CGRP. Eur. J. Med. Chem.168, 146–153. 10.1016/j.ejmech.2019.02.037
77
MacphersonL. J.GeierstangerB. H.ViswanathV.BandellM.EidS. R.HwangS.et al (2005). The pungency of garlic: activation of TRPA1 and TRPV1 in response to allicin. Curr. Biol.15 (10), 929–934. 10.1016/j.cub.2005.04.018
78
MaglieR.Souza Monteiro de AraujoD.AntigaE.GeppettiP.NassiniR.De LoguF. (2021). The role of TRPA1 in skin physiology and pathology. Int. J. Mol. Sci.22 (6), 3065. 10.3390/ijms22063065
79
MatsumotoT.TakiyamaM.SanechikaS.NakayamaA.AokiK.OhbuchiK.et al (2020). In vivo pharmacokinetic analysis utilizing non-targeted and targeted mass spectrometry and in vitro assay against transient receptor potential channels of maobushisaishinto and its constituent asiasari radix. Molecules25 (18), 4283. 10.3390/molecules25184283
80
MeiY.LiL.FanL.FanW.LiuL.ZhangF.et al (2023). The history, stereochemistry, ethnopharmacology and quality assessment of borneol. J. Ethnopharmacol.300, 115697. 10.1016/j.jep.2022.115697
81
MemonT.YarishkinO.ReillyC. A.KrižajD.OliveraB. M.TeichertR. W. (2019). trans-Anethole of fennel oil is a selective and nonelectrophilic agonist of the TRPA1 ion channel. Mol. Pharmacol.95 (4), 433–441. 10.1124/mol.118.114561
82
MizunoK.KonoT.SuzukiY.MiyagiC.OmiyaY.MiyanoK.et al (2014). Goshajinkigan, a traditional Japanese medicine, prevents oxaliplatin-induced acute peripheral neuropathy by suppressing functional alteration of TRP channels in rat. J. Pharmacol. Sci.125 (1), 91–98. 10.1254/jphs.13244FP
83
MooreC.GuptaR.JordtS.-E.ChenY.LiedtkeW. B. (2017). Regulation of pain and itch by TRP channels. Neurosci. Bull.34 (1), 120–142. 10.1007/s12264-017-0200-8
84
MorelliM. B.AmantiniC.LiberatiS.SantoniM.NabissiM. (2013). TRP channels: new potential therapeutic approaches in CNS neuropathies. CNS Neurol. Disord. Drug Targets12 (2), 274–293. 10.2174/18715273113129990056
85
MuhozaB.QiB.HarindintwaliJ. D.KokoM. Y. F.ZhangS.LiY. (2023). Encapsulation of cinnamaldehyde: an insight on delivery systems and food applications. Crit. Rev. Food Sci. Nutr.63 (15), 2521–2543. 10.1080/10408398.2021.1977236
86
NawazJ.RasulA.ShahM. A.HussainG.RiazA.SarfrazI.et al (2020). Cardamonin: a new player to fight cancer via multiple cancer signaling pathways. Life Sci.250, 117591. 10.1016/j.lfs.2020.117591
87
NiliusB.PrenenJ.OwsianikG. (2011). Irritating channels: the case of TRPA1. J. Physiology589 (7), 1543–1549. 10.1113/jphysiol.2010.200717
88
OkumuraY.NarukawaM.IwasakiY.IshikawaA.MatsudaH.YoshikawaM.et al (2014). Activation of TRPV1 and TRPA1 by black pepper components. Biosci. Biotechnol. Biochem.74 (5), 1068–1072. 10.1271/bbb.90964
89
OrtarG.Schiano MorielloA.MoreraE.NalliM.Di MarzoV.De PetrocellisL. (2013). 3-Ylidenephthalides as a new class of transient receptor potential channel TRPA1 and TRPM8 modulators. Bioorg. and Med. Chem. Lett.23 (20), 5614–5618. 10.1016/j.bmcl.2013.08.039
90
OzhanO.IzciS. F.HuzM.ColakM.KucukakcaliZ.ParlakpinarH. (2023). Therapeutic effects of cinnamon bark oil on sciatic nerve injury in rats. Eur. Rev. Med. Pharmacol. Sci.27 (12), 5841–5853. 10.26355/eurrev_202306_32823
91
PanY.ZhaoG.CaiZ.ChenF.XuD.HuangS.et al (2016). Synergistic effect of ferulic acid and Z-ligustilide, major components ofA. Sinensis, on regulating cold-sensing protein TRPM8 and TPRA1in vitro. Evidence-Based Complementary Altern. Med.2016, 3160247–10. 10.1155/2016/3160247
92
Paricio-MontesinosR.SchwallerF.UdhayachandranA.RauF.WalcherJ.EvangelistaR.et al (2020). The sensory coding of warm perception. Neuron106 (5), 830–841. 10.1016/j.neuron.2020.02.035
93
ParkM. K.LeeH. J.ChoiJ. K.KimH. J.KangJ. H.LeeE. J.et al (2014). Novel anti-nociceptive effects of cardamonin via blocking expression of cyclooxygenase-2 and transglutaminase-2. Pharmacol. Biochem. Behav.118, 10–15. 10.1016/j.pbb.2013.12.019
94
ParkY. M.LeeH. Y.ShinD. Y.KimD. S.YooJ. J.YangH. J.et al (2022). Immune-enhancing effects of Co-treatment with Kalopanax pictus Nakai bark and Nelumbo nucifera gaertner leaf extract in a cyclophosphamide-induced immunosuppressed rat model. Front. Nutr.9, 898417. 10.3389/fnut.2022.898417
95
PatilM. J.HuangY.YuM.DongX.UndemB. J.YuS. (2022). Ginger constituent 6-shogaol attenuates vincristine-induced activation of mouse gastroesophageal vagal afferent C-fibers. Molecules27 (21), 7465. 10.3390/molecules27217465
96
PaulsenC. E.ArmacheJ.-P.GaoY.ChengY.JuliusD. (2015). Structure of the TRPA1 ion channel suggests regulatory mechanisms. Nature520 (7548), 511–517. 10.1038/nature14367
97
PaumierA.BoisseauS.Jacquier-SarlinM.Pernet-GallayK.BuissonA.AlbrieuxM. (2022). Astrocyte-neuron interplay is critical for Alzheimer's disease pathogenesis and is rescued by TRPA1 channel blockade. Brain145 (1), 388–405. 10.1093/brain/awab281
98
PengS.LiJ.HuoM.CaoY.ChenZ.ZhangY.et al (2022). Identification of the material basis of the medicinal properties in Curcuma Longa L. to enhance targeted clinical application. J. Traditional Chin. Med. Sci.9 (4), 374–382. 10.1016/j.jtcms.2022.07.001
99
Pourbagher-ShahriA. M.ForouzanfarF. (2023). Saffron (Crocus sativus) and its constituents for pain management: a review of current evidence. Phytother. Res.37 (11), 5041–5057. 10.1002/ptr.7968
100
QiJ.PanZ.WangX.ZhangN.HeG.JiangX. (2024). Research advances of Zanthoxylum bungeanum Maxim. polyphenols in inflammatory diseases. Front. Immunol.15, 1305886. 10.3389/fimmu.2024.1305886
101
RaiU.KosuruR.PrakashS.SinghS. P.BirlaH.TiwariV.et al (2019). Tetramethylpyrazine prevents diabetes by activating PI3K/Akt/GLUT-4 signalling in animal model of type-2 diabetes. Life Sci.236, 116836. 10.1016/j.lfs.2019.116836
102
RenY.QuS. (2023). Constituent isoflavones of Puerariae radix as a potential neuroprotector in cognitive impairment: evidence from preclinical studies. Ageing Res. Rev.90, 102040. 10.1016/j.arr.2023.102040
103
RuanY.JinX.JiH.ZhuC.YangY.ZhouY.et al (2023). Water extract of Notopterygium incisum alleviates cold allodynia in neuropathic pain by regulation of TRPA1. J. Ethnopharmacol.305, 116065. 10.1016/j.jep.2022.116065
104
SchwartzE. S.LaJ.-H.ScheffN. N.DavisB. M.AlbersK. M.GebhartG. F. (2013). TRPV1 and TRPA1 antagonists prevent the transition of acute to chronic inflammation and pain in chronic pancreatitis. J. Neurosci.33 (13), 5603–5611. 10.1523/jneurosci.1806-12.2013
105
ShiH.-L.LiuC. H.DingL. L.ZhengY.FeiX. Y.LuL.et al (2015). Alterations in serotonin, transient receptor potential channels and protease-activated receptors in rats with irritable bowel syndrome attenuated by Shugan decoction. World J. Gastroenterology21 (16), 4852–4863. 10.3748/wjg.v21.i16.4852
106
ShimizuT.TerawakiK.SekiguchiK.SanechikaS.OhbuchiK.MatsumotoC.et al (2022). Tokishakuyakusan ameliorates lowered body temperature after immersion in cold water through the early recovery of blood flow in rats. J. Ethnopharmacol.285, 114896. 10.1016/j.jep.2021.114896
107
SonH. J.KimM. J.ParkJ.-H.IshiiS.MisakaT.RhyuM.-R. (2012a). Methyl syringate, a low-molecular-weight phenolic ester, as an activator of the chemosensory ion channel TRPA1. Archives Pharmacal Res.35 (12), 2211–2218. 10.1007/s12272-012-1220-6
108
SonH. J.KimY.MisakaT.NohB. S.RhyuM.-R. (2012b). Activation of the chemosensory ion channels TRPA1 and TRPV1 by hydroalcohol extract of Kalopanax pictus leaves. Biomol. Ther.20 (6), 550–555. 10.4062/biomolther.2012.20.6.550
109
SongJ.JiangM.JinY.LiH.LiY.LiuY.et al (2023). Phytol from Faeces Bombycis alleviated migraine pain by inhibiting Nav1.7 sodium channels. J. Ethnopharmacol.306, 116161. 10.1016/j.jep.2023.116161
110
Souza Monteiro de AraujoD.NassiniR.GeppettiP.De LoguF. (2020). TRPA1 as a therapeutic target for nociceptive pain. Expert Opin. Ther. Targets24 (10), 997–1008. 10.1080/14728222.2020.1815191
111
SunP.ZhaoW.WangQ.ChenL.SunK.ZhanZ.et al (2022a). Chemical diversity, biological activities and Traditional uses of and important Chinese herb Sophora. Phytomedicine100, 154054. 10.1016/j.phymed.2022.154054
112
SunY.-b.NiY.FanX.-s.ZhouL.-p.YueQ.-f.ShangE.-x. (2022b). Effect of Houpo-Mahuang Decoction on aggravated asthma induced by cigarette smoke and the expression of TRPA1 and tight junctions in mice. J. Ethnopharmacol.293, 115217. 10.1016/j.jep.2022.115217
113
TakaishiM.UchidaK.FujitaF.TominagaM. (2013). Inhibitory effects of monoterpenes on human TRPA1 and the structural basis of their activity. J. Physiological Sci.64 (1), 47–57. 10.1007/s12576-013-0289-0
114
TakooreeH.AumeeruddyM. Z.RengasamyK. R. R.VenugopalaK. N.JeewonR.ZenginG.et al (2019). A systematic review on black pepper (Piper nigrum L.): from folk uses to pharmacological applications. Crit. Rev. Food Sci. Nutr.59 (Suppl. 1), S210-S243–S243. 10.1080/10408398.2019.1565489
115
TalaveraK.StartekJ. B.Alvarez-CollazoJ.BoonenB.AlpizarY. A.SanchezA.et al (2020). Mammalian transient receptor potential TRPA1 channels: from structure to disease. Physiol. Rev.100 (2), 725–803. 10.1152/physrev.00005.2019
116
TeixeiraF.SilvaA. M.Delerue-MatosC.RodriguesF. (2023). Lycium barbarum berries (Solanaceae) as source of bioactive compounds for healthy purposes: a review. Int. J. Mol. Sci.24 (5), 4777. 10.3390/ijms24054777
117
TianK.-m.LiJ.-j.XuS.-w. (2019). Rutaecarpine: a promising cardiovascular protective alkaloid from Evodia rutaecarpa (Wu Zhu Yu). Pharmacol. Res.141, 541–550. 10.1016/j.phrs.2018.12.019
118
TianW.HeD.LiuJ.ChenF.ZhangW.HuJ.et al (2023). Topical borneol relieves nonhistaminergic pruritus via targeting TRPA1 and TRPM8 channels in peripheral nerve terminals of mice. Eur. J. Pharmacol.953, 175833. 10.1016/j.ejphar.2023.175833
119
TuY. (2011). The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine. Nat. Med.17 (10), 1217–1220. 10.1038/nm.2471
120
WangC.LiuC.WanH.WangD.SunD.XuT.et al (2015). Wu-tou decoction inhibits chronic inflammatory pain in mice: participation of TRPV1 and TRPA1 ion channels. BioMed Res. Int.2015, 328707–328712. 10.1155/2015/328707
121
WangJ.WangL.ZhouH.LiangX.-d.ZhangM.-t.TangY.-x.et al (2022). The isolation, structural features and biological activities of polysaccharide from Ligusticum chuanxiong: a review. Carbohydr. Polym.285, 118971. 10.1016/j.carbpol.2021.118971
122
WangM.YaoM.LiuJ.TakagiN.YangB.ZhangM.et al (2020). Ligusticum chuanxiong exerts neuroprotection by promoting adult neurogenesis and inhibiting inflammation in the hippocampus of ME cerebral ischemia rats. J. Ethnopharmacol.249, 112385. 10.1016/j.jep.2019.112385
123
WangM.ZhangY.XuM.ZhangH.ChenY.ChungK. F.et al (2019a). Roles of TRPA1 and TRPV1 in cigarette smoke -induced airway epithelial cell injury model. Free Radic. Biol. Med.134, 229–238. 10.1016/j.freeradbiomed.2019.01.004
124
WangP.LiuH.FanX.ZhuZ.ZhuY. (2019b). Effect of San'ao decoction on aggravated asthma mice model induced by PM2.5 and TRPA1/TRPV1 expressions. J. Ethnopharmacol.236, 82–90. 10.1016/j.jep.2019.02.043
125
WangP.ShangE.FanX. (2021). Effect of San'ao decoction with scorpio and bombyx batryticatus on CVA mice model via airway inflammation and regulation of TRPA1/TRPV1/TRPV5 channels. J. Ethnopharmacol.264, 113342. 10.1016/j.jep.2020.113342
126
WangS.ZhaiC.ZhangY.YuY.ZhangY.MaL.et al (2016). Cardamonin, a novel antagonist of hTRPA1 cation channel, reveals therapeutic mechanism of pathological pain. Molecules21 (9), 1145. 10.3390/molecules21091145
127
WangS.ZhangD.HuJ.JiaQ.XuW.SuD.et al (2017). A clinical and mechanistic study of topical borneol‐induced analgesia. EMBO Mol. Med.9 (6), 802–815. 10.15252/emmm.201607300
128
WeiW.-L.ZengR.GuC.-M.QuY.HuangL.-F. (2016). Angelica sinensis in China-A review of botanical profile, ethnopharmacology, phytochemistry and chemical analysis. J. Ethnopharmacol.190, 116–141. 10.1016/j.jep.2016.05.023
129
WeiY.SuiD.-J.XuH.-M.OuyangZ.WuN.WangD.-J.et al (2017). Atractylodes lancea rhizome water extract reduces triptolide-induced toxicity and enhances anti-inflammatory effects. Chin. J. Nat. Med.15 (12), 905–911. 10.1016/s1875-5364(18)30006-2
130
WuC. K.LinJ. F.LeeT. S.KouY. R.TarngD. C. (2021a). Role of TRPA1 in tissue damage and kidney disease. Int. J. Mol. Sci.22 (7), 3415. 10.3390/ijms22073415
131
WuD.LiX.LiuJ.HuC.LiJ. (2021b). Wutou decoction attenuates rheumatoid arthritis by modulating the Ahr/LOC101928120/SHC1 pathway. Pharm. Biol.59 (1), 811–822. 10.1080/13880209.2021.1941131
132
WuP.HuangZ.ShanJ.LuoZ.ZhangN.YinS.et al (2020). Interventional effects of the direct application of “Sanse powder” on knee osteoarthritis in rats as determined from lipidomics via UPLC-Q-Exactive Orbitrap MS. Chin. Med.15, 9. 10.1186/s13020-020-0290-5
133
XiaZ.-Y.XieH.-T.PanX.ZhaoB.LiuZ.-G. (2018). Puerarin ameliorates allodynia and hyperalgesia in rats with peripheral nerve injury. Neural Regen. Res.13 (7), 1263–1268. 10.4103/1673-5374.235074
134
XiangH.ZuoJ.GuoF.DongD. (2020). What we already know about rhubarb: a comprehensive review. Chin. Med.15 (1), 88. 10.1186/s13020-020-00370-6
135
XiangL.BoX.XinL.JiangX.-w.LuH.-y.XuZ.-H.et al (2021). Network pharmacology-based research uncovers cold resistance and thermogenesis mechanism of Cinnamomum cassia. Fitoterapia149, 104824. 10.1016/j.fitote.2020.104824
136
XiaoZ.DengQ.ZhouW.ZhangY. (2022). Immune activities of polysaccharides isolated from Lycium barbarum L. What do we know so far?Pharmacol. and Ther.229, 107921. 10.1016/j.pharmthera.2021.107921
137
XuH.BlairN. T.ClaphamD. E. (2005). Camphor activates and strongly desensitizes the transient receptor potential vanilloid subtype 1 channel in a vanilloid-independent mechanism. J. Neurosci.25 (39), 8924–8937. 10.1523/jneurosci.2574-05.2005
138
YanB.ShenM.FangJ.WeiD.QinL. (2018). Advancement in the chemical analysis of Paeoniae radix (Shaoyao). J. Pharm. Biomed. Analysis160, 276–288. 10.1016/j.jpba.2018.08.009
139
YanC.PengT.ZhangT.WangY.LiN.WangK.et al (2023). Molecular mechanisms of hepatotoxicity induced by compounds occurring in Evodiae Fructus. Drug Metab. Rev.55 (1-2), 75–93. 10.1080/03602532.2023.2180027
140
YanC.WuW.DongW.ZhuB.ChangJ.LvY.et al (2022). Temperature acclimation in hot-spring snakes and the convergence of cold response. Innov. (Camb)3 (5), 100295. 10.1016/j.xinn.2022.100295
141
YangH.MingY.WangW.JinY.HaoZ.LiuG.et al (2022). Anti-inflammatory and anti-pruritic effects of Chi-Huang Solution in a murine model of allergic contact dermatitis. J. Ethnopharmacol.298, 115543. 10.1016/j.jep.2022.115543
142
YangM.-Q.YeL.-L.LiuX.-L.QiX.-M.LvJ.-D.WangG.et al (2016). Gingerol activates noxious cold ion channel TRPA1 in gastrointestinal tract. Chin. J. Nat. Med.14 (6), 434–440. 10.1016/s1875-5364(16)30040-1
143
YangR.YuanB. C.MaY. S.ZhouS.LiuY. (2017). The anti-inflammatory activity of licorice, a widely used Chinese herb. Pharm. Biol.55 (1), 5–18. 10.1080/13880209.2016.1225775
144
YangT.ZhaoS.YuanY.ZhaoX.BuF.ZhangZ.et al (2023). Platycodonis radix alleviates LPS-induced lung inflammation through modulation of TRPA1 channels. Molecules28 (13), 5213. 10.3390/molecules28135213
145
YaoK.DouB.ZhangY.ChenZ.LiY.FanZ.et al (2023). Inflammation—the role of TRPA1 channel. Front. Physiology14, 1093925. 10.3389/fphys.2023.1093925
146
YeM.FengQ.JiangY.WangF.ShiX.YangX.et al (2023). Structure characterization and anti‐rheumatoid arthritis activity of a polysaccharide from Notopterygium incisum. Mol. Nutr. and Food Res.67 (15), e2200713. 10.1002/mnfr.202200713
147
YuM.YeF.MaC.JinX.JiH.WangD.et al (2022). Ligustrazine mitigates chronic venous disease-induced pain hyperalgesia through desensitization of inflammation-associated TRPA1 activity in DRG. J. Ethnopharmacol.298, 115667. 10.1016/j.jep.2022.115667
148
YuX.YuM.LiuY.YuS. (2016). TRP channel functions in the gastrointestinal tract. Semin. Immunopathol.38 (3), 385–396. 10.1007/s00281-015-0528-y
149
YuanR.TaoX.LiangS.PanY.HeL.SunJ.et al (2018). Protective effect of acidic polysaccharide from Schisandra chinensis on acute ethanol-induced liver injury through reducing CYP2E1-dependent oxidative stress. Biomed. Pharmacother.99, 537–542. 10.1016/j.biopha.2018.01.079
150
ZhanY.WenY.ZhangL.-l.ShenX.-l.ChenX.-h.WuX.-h.et al (2021). Paeoniflorin improved constipation in the loperamide-induced rat model via TGR5/TRPA1 signaling-mediated 5-hydroxytryptamine secretion. Evidence-Based Complementary Altern. Med.2021, 6076293–19. 10.1155/2021/6076293
151
ZhangD.ChenD.MaS. S.BianW. Y.XieF.HuangM. N.et al (2019). Effect of Danggui Sini decoction on the behaviour and dorsal root ganglion TRP channel of neuropathic pain in CCI rats. Indian J. Pharm. Sci.81 (5), 922–932. 10.36468/pharmaceutical-sciences.587
152
ZhangD.JingB.LiX.ShiH.ChenZ.ChangS.et al (2022). Antihyperalgesic effect of paeniflorin based on chronic constriction injury in rats. Rev. Bras. Farmacogn.32 (3), 375–385. 10.1007/s43450-022-00251-z
153
ZhangD.SunJ.YangB.MaS.ZhangC.ZhaoG. (2020a). Therapeutic effect of Tetrapanax papyriferus and hederagenin on chronic neuropathic pain of chronic constriction injury of sciatic nerve rats based on KEGG pathway prediction and experimental verification. Evidence-Based Complementary Altern. Med.2020, 2545806–2545811. 10.1155/2020/2545806
154
ZhangD.YangB.ChangS.-Q.MaS.-S.SunJ.-X.YiL.et al (2021a). Protective effect of paeoniflorin on H2O2 induced Schwann cells injury based on network pharmacology and experimental validation. Chin. J. Nat. Med.19 (2), 90–99. 10.1016/s1875-5364(21)60010-9
155
ZhangH. A.KittsD. D. (2021). Turmeric and its bioactive constituents trigger cell signaling mechanisms that protect against diabetes and cardiovascular diseases. Mol. Cell. Biochem.476 (10), 3785–3814. 10.1007/s11010-021-04201-6
156
ZhangL.WeiW. (2020). Anti-inflammatory and immunoregulatory effects of paeoniflorin and total glucosides of paeony. Pharmacol. Ther.207, 107452. 10.1016/j.pharmthera.2019.107452
157
ZhangL. L.HuangM. Y.YangY.HuangM. Q.ShiJ. J.ZouL.et al (2020b). Bioactive platycodins from Platycodonis Radix: phytochemistry, pharmacological activities, toxicology and pharmacokinetics. Food Chem.327, 127029. 10.1016/j.foodchem.2020.127029
158
ZhangM.XuC.LiuD.HanM. K.WangL.MerlinD. (2018). Oral delivery of nanoparticles loaded with ginger active compound, 6-shogaol, attenuates ulcerative colitis and promotes wound healing in a murine model of ulcerative colitis. J. Crohn's Colitis12 (2), 217–229. 10.1093/ecco-jcc/jjx115
159
ZhangM. M.DangM.WuX.OuL.LiM.ZhaoC. B.et al (2024). Da-Jian-Zhong decoction alleviates diarrhea-predominant irritable bowel syndrome via modulation of gut microbiota and Th17/Treg balance. J. Ethnopharmacol.331, 118275. 10.1016/j.jep.2024.118275
160
ZhangW.LeiW.ShenF.WangM.LiL.ChangJ. (2023). Cinnamaldehyde induces apoptosis and enhances anti-colorectal cancer activity via covalent binding to HSPD1. Phytother. Res.38, 4957–4966. 10.1002/ptr.7840
161
ZhangZ.PanJ.ZhuT.MalewiczN.YeK.RongJ.et al (2021b). Oxymatrine screened from Sophora flavescens by cell membrane immobilized chromatography relieves histamine-independent itch. J. Pharm. Pharmacol.73 (12), 1617–1629. 10.1093/jpp/rgab145
162
ZhaoJ.Lin KingJ. V.PaulsenC. E.ChengY.JuliusD. (2020). Irritant-evoked activation and calcium modulation of the TRPA1 receptor. Nature585 (7823), 141–145. 10.1038/s41586-020-2480-9
163
ZhaoY. D.YanX. N.JiangS. S.LiuY.DongC.ChiH. Y.et al (2023). Zhenxin Anshen formula ameliorates atopic der-matitis-like skin dysfunction in mice and in vitro via regulation of transient receptor potential vanilloid 1 and transient receptor potential ankyrin 1 in Neural pathways. J. Traditional Chin. Med.43 (5), 887–896. 10.19852/j.cnki.jtcm.20230802.003
164
ZhengJ.ZhouY.LiY.XuD.-P.LiS.LiH.-B. (2016). Spices for prevention and treatment of cancers. Nutrients8 (8), 495. 10.3390/nu8080495
165
ZhiX.RenC.LiQ.XiH.LiD.ChenQ.et al (2024). Therapeutic potential of Angelica sinensis in addressing organ fibrosis: a comprehensive review. Biomed. Pharmacother.173, 116429. 10.1016/j.biopha.2024.116429
166
ZhongJ.LiuZ.ZhouX.XuJ. (2017). Synergic anti-pruritus mechanisms of action for the radix sophorae Flavescentis and Fructus Cnidii herbal pair. Molecules22 (9), 1465. 10.3390/molecules22091465
167
ZhongJ.PollastroF.PrenenJ.ZhuZ.AppendinoG.NiliusB. (2011). Ligustilide: a novel TRPA1 modulator. Pflügers Archiv - Eur. J. Physiology462 (6), 841–849. 10.1007/s00424-011-1021-7
168
ZhongS.NieY.-c.GanZ.-y.LiuX.-d.FangZ.-f.ZhongB.-n.et al (2015). Effects of Schisandra chinensis extracts on cough and pulmonary inflammation in a cough hypersensitivity Guinea pig model induced by cigarette smoke exposure. J. Ethnopharmacol.165, 73–82. 10.1016/j.jep.2015.02.009
169
ZhouH.-H.ZhangL.ZhouQ.-G.FangY.GeW.-H. (2016). (+)-Borneol attenuates oxaliplatin-induced neuropathic hyperalgesia in mice. NeuroReport27 (3), 160–165. 10.1097/wnr.0000000000000516
170
ZhouX.XiangK.YuanX.WangZ.LiK. (2020). Chinese herbal medicine Wutou decoction for knee osteoarthritis: a protocol for systematic review and meta-analysis. Medicine99 (43), e22767. 10.1097/md.0000000000022767
171
ZhouX. L.ChenL. L.WangJ. F. (2022). Study on the antipruritic mechanism of Zanthoxylum bungeanum and Zanthoxylum schinifolium volatile oil on chronic eczema based on H1R and PAR-2 mediated GRPR pathway. Allergologia Immunopathol.50 (4), 83–96. 10.15586/aei.v50i4.486
172
ZhuR.LiuH.LiuC.WangL.MaR.ChenB.et al (2017). Cinnamaldehyde in diabetes: a review of pharmacology, pharmacokinetics and safety. Pharmacol. Res.122, 78–89. 10.1016/j.phrs.2017.05.019
173
ZhuT.ZhouD.ZhangZ.LongL.LiuY.FanQ.et al (2020). Analgesic and antipruritic effects of oxymatrine sustained-release microgel cream in a mouse model of inflammatory itch and pain. Eur. J. Pharm. Sci.141, 105110. 10.1016/j.ejps.2019.105110
174
ZouJ.GaoP.HaoX.XuH.ZhanP.LiuX. (2018). Recent progress in the structural modification and pharmacological activities of ligustrazine derivatives. Eur. J. Med. Chem.147, 150–162. 10.1016/j.ejmech.2018.01.097
175
ZsombokA.DerbenevA. (2016). TRP channels as therapeutic targets in diabetes and obesity. Pharmaceuticals9 (3), 50. 10.3390/ph9030050
176
ZygmuntP. M.HögestättE. D. (2014). “Trpa1,” in Mammalian transient receptor potential (TRP) cation channels, 583–630.
Summary
Keywords
TRPA1, traditional Chinese medicine, Chinese herbal medicinal properties, natural compounds, pain, hyperalgesia, inflammatory disease
Citation
Fang Y, Lei C, Wang Z, Liu L, Chen Y, Chen F, Li J, Tu Z, Tao Q and Xu Y (2025) Regulation of transient receptor potential ankyrin 1 by traditional Chinese medicine drugs and their active ingredients. Front. Pharmacol. 16:1604765. doi: 10.3389/fphar.2025.1604765
Received
02 April 2025
Accepted
27 May 2025
Published
06 June 2025
Volume
16 - 2025
Edited by
Javier Echeverria, University of Santiago, Chile
Reviewed by
Grigori Rychkov, University of Adelaide, Australia
Gerard Ahern, Georgetown University, United States
Updates
Copyright
© 2025 Fang, Lei, Wang, Liu, Chen, Chen, Li, Tu, Tao and Xu.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Yuan Xu, xuyuan2004020@163.com; Qingwen Tao, taoqg1@sina.com
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.